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INTRODUCTION
The fibrinolytic process is concerned with the enzy¬
matic dissolution of fibrin. The end-product is a single
proteolytic enzyme, plasmin, which is responsible for the
action of fibrinolysis. The proteolytic actions of
plasmin are protean but in the presence of inhibitors in
the blood it attacks only fibrin, to which it is adsorbed
(Macfarlane and Biggs 1948, Celander and Guest 1957).
Plasmin is derived from a stable inactive precursor named
plasminogen which is present in the globulin fraction of
plasma. Conversion of plasminogen to plasmin usually
requires an activator or activating system.
Recent research in the field of fibrinolysis has been
centred upon the therapeutic application of exogenous
activators in thrombo-embolic disease (McNicol and Douglas
1964) and the relationship between excess fibrinolysis to
severe haemorrhage (Sharp 1964) and diminished fibrino¬
lysis in various pathological states (Fearnley 1965).
Despite this increased activity our knowledge of the
physiological roles of the fibrinolytic enzyme system
remains fragmentary. The studies outlined in this thesis




THE DEVELOPMENT OF THE MODERN CONCEPTS
OF THE FIBRINOLYTIC ENZYME SYSTEM
Over 200 years ago Morgagni (176♦), in his famous
work "De Gedibus et Causis Morborum," reported that blood
remained fluid in cases of sudden death. In 1794 John
Hunter reported fluidity of blood in the cadaver and
Denis (1838) and Zimmerman (1846) observed that the fibrin
of human blood, obtained by wet cupping, sometimes dissol¬
ved in the absence of bacterial contamination. Green
(1887) found that fibrin lysed in saline would not clot
again on addition of thrombin. Dastre (1893) using dog
fibrin as a substrate for studies on gastric enzymes
observed that the substrate appeared to digest itself and
he proposed the term fibrinolysis for this phenomenon.
Nolf (1905, 1908) stressed that fibrinolysis must be due
to a proteolytic enzyme and that this process was a basic
mechanism of cellular nutrition.
.Almost 30 years elapsed before any further major
advance was made when Tillettand Garner (1933) reported
that rapid lysis occurred in plasma clots incubated with
extracts of beta-haemolytic streptococci. It was assumed
that the extract contained a proteolytic enzyme specifi¬
cally adapted for fibrinogen and fibrin, but Milstone
(1941) observed no lysis with this extract on purified
fibrinogen unless small amounts of a serum fraction
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containing globulin were added. Christensen (1945) and
Kaplan (1944), independently, concluded that the strepto¬
coccal factor was an activator of a precursor proact i vator,
present in the euglobulin fraction of human blood plasma
or serum. Christensen and MacLeod (1945) proposed a new
terminology for the factors involved: the active proteo¬
lytic enzyme was named plasmin, the precursor became
plasminogen, the streptococcal activator streptokinase and
the inhibitor antiplasmin.
Fig. 1 summarises briefly the basic structure of the
fibrinolytic enzyme system, as envisaged at present.
More recent developments had been centred upon the
isolation of plasminogen and plasmin, the activation of
plasminogen to plasmin and a more detailed study of the
inhibitor mechanisms, all of which will be discussed in
the subsequent section.
a. the components of the fibrinolytic enzyme system
1• plasminogen
Plasminogen is a (3-globulin (Robbins and Summaria
1963) present in the euglobulin fraction of plasma
(Milstone 1941). Major advances in isolation, purifica¬
tion and characterisation of human plasminogen were made























Fig.1. Simplified Scheme of Fibrinolysis.
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his colleagues (Kline 1953, Kline and Fishman 1961).
More recently, using chromatographic techniques, it has
been possible to obtain preparations of higher specific
activity (Alkjaersig I960, Derechin et al. 1962, Robbins
and Summaria 1964), but this has resulted in discordant
observations on molecular weight (83,000 - 143,000),
solubility characteristics, e1ectrophoretic and ultra-
centrifugal behaviour, so that some preparations appeared
to contain multiple species of plasminogen. In an effort
to clarify this problem, Alkjaersig (1964) has concluded
that the molecular characteristics of plasminogen may vary
with the method of purification and that the molecule
probably has a great deal of plasticity in terms of its
secondary and tertiary structure.
The source of plasma plasminogen remains uncertain:
Barnhart and Riddle (1963), on the basis of immunofluores-
cent studies, have suggested that the bone marrow eosino¬
phil is a major source. It is also probable that the
liver (Sherry 1965) and arterial intima (Todd 1964) may
play significant roles.
Plasminogen is widely distributed throughout the
body; its concentration in plasma has been estimated at
0.1 - 0.2 mg./ml. It has a tendency to co-precipitate
with fibrin, so that significant quantities of plasminogen
are incorporated into such deposits (vide infra).
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2. PLASMIN
Despite the recent use of stabilizing agents, such as
glycerol and lysine, in the activating mixtures of highly
purified plasminogen preparations (Alkjaersig et al. 1958,
Kline and Fishman 1964), the biophysical characteristics
of plasmin await clarification, largely due to the problem
of multimolecular species of plasminogen, discussed above.
The biochemical activity, however, has been well charac¬
terised (Sherry et al . 1959 Abl ondi and Hagan I960). It
is a proteolytic enzyme of the endopeptidase type and can
hydrolyse susceptible arginine and lysine bonds in
proteins. Plasmin will digest fibrinogen in a manner and
rate similar to its action on fibrin. It attacks a
number of other plasma proteins including coagulation
factors V and VIII. This dangerously protean proteolytic
enzyme is kept in check by a large amount of circulating
anti-piasmins (Norman 1966).
Plasmin breaks down fibrinogen and fibrin into small
polypeptide moieties which may yet be shown to play a
vital role in the proposed link between coagulation and
fibrinolysis, for they can interfere with fibrin polymeri¬
sation (Alkjaersig et al. 1962) and platelet aggregation
(Jerushalmy and Zucker 1966).
3. PLASMINOGEN ACTIVATORS
These are substances, either endogenous or exogenous,
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which convert plasminogen to plasmin. They can be
classified as physiological or non-physiological.
{a) Non-physiological activators
Streptokinase
This is an extracellular bacterial protein (molecular
weight 50,000) derived from actively growing haemolytic
streptococci - Lancefield's Group A, C and G. While it
has no physiological role in man it has been used exten¬
sively both as a laboratory and therapeutic agent.
Streptokinase converts plasminogen to plasmin in
human plasma but is unable to do so in bovine plasma,
unless a trace amount of human serum or plasma is present.
These findings led Geiger (1952) and Mullertz (1957) to
conclude that streptokinase activation of plasminogen by
streptokinase was an indirect one requiring the presence
of a proactivator, normally present in human serum and
plasma. Whether proactivator exists as a separate and
distinct entity remains unsettled. However, data follow¬
ing the recent isolation of purified plasminogen (Kline
and Fishman 1961, De Renzo et al. 1963, Alkjaersig 1964)
ifavours the concept that streptokinase interacts with
human plasminogen and/or plasmin to form a product with
activator activity and that this reaction does not require
the presence of an additional plasma factor. Until this




Staphylokinase is present in cultured filtrates of
some strains of staphylococci (Gerheim et al. 1948, Lack
1948). Staphy1okinase activates plasminogen directly
(Lewis and Ferguson 1951), but there appears to be con¬
siderable species difference in susceptibility (Cliffton
and Cannamela 1952).
Non-specific plasminogen activation
There are a number of compounds, including peptone
(Astrup and Olesen 1957 ), urea (Von Kaulla and Smith 1961)
hydrophobic compounds (Von Kaulla 1961), heparin (Halse
I960) and protamine (Von Kaulla 1952), which have been
shown to increase in vitro plasma fibrinolytic activity.
Although it has generally been concluded that their
primary mode of action is a destruction of anti-fibrino¬
lytic substances, Olesen (1965) has postulated a cleavage
of an activator-anti-activator complex by physico-




Fischer (1946) first demonstrated that normal tissues
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contained plasminogen activator, and this was subsequently-
confirmed by Astrup and Permin (1948), Tagnon and Palade
(1950) and Lewis and Ferguson (1950): the latter workers
considered it was located in the microsomal fraction.
Lack and Ali (1964) have repeated this work and observed
highest activity in the lysosomal fraction.
In an extensive study on the tissue content of plas¬
minogen activator in different tissues, A1brechtsen ( 1957 )
found the uterus, adrenals, lymph nodes, prostate and lung
tissues to contain high levels, but the normal liver
failed to show activity.
Tissue activator was considered to exist in two forms,,
soluble and insoluble in saline, but it is probable that
the soluble form may represent contaminating blood activa¬
tor content. The insoluble fraction can be extracted by
2 M potassium thiocyanate. Activator prepared in this
way is remarkably stable, resisting temperatures of 50° C.
for 30 minutes over a wide pH range (Astrup and Sterndorff
1956). Further biochemical and biophysical characterisa¬
tion has been impeded since the thiocyanate extraction
procedure does not lend itself to further purification.
Bachmann et al. (1964) have re-investigated this problem
jand, by using new chromatographic procedures, have
achieved a major breakthrough in purification of plasmino¬
gen activator from pig heart. It is to be expected that
in the next few years, v/hen the new methods of purifica¬
tion have been fully exploited, a much greater degree of
I
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information on the properties and mechanism of action
will be available.
The biological significance of tissue activators
remains to be elucidated. They may prove to make a
significant contribution to the circulating activator
(Maki et al. 1965) and also be essential in connective
tissue repair mechanisms (Astrup 1966).
Urokinase
Williams (1951) confirmed the earlier observations of;
Macfarlane and Pilling (1947) that fibrinolytic activity
was present in urine and further demonstrated it to be a
plasminogen activator. It has been fairly extensively
purified and characterised (Ploug and Kjeldgaard 1957,
Sgouris et al. 1962, Bergstrom 1963), and appears to con¬
vert plasminogen to plasmin by first order kinetics
(Kjeldgaard and Ploug 1957, Alkjaersig et al. 1958).
Whether it represents cleared plasma activator and/or a
renal product remains to be determined (Smyrniotis et al.
1959, Celander and Guest I960, Holemans et al. 1966,
Charlton 1966). The physiological function of urokinase
is also speculative, but it may play a part in maintaining;
an unobstructed urine flow.
Although recent commercial products have been shown
to be contaminated by thrombop1 astic materials (Douglas
and McNicol 1964) it is currently undergoing extensive
clinical trials as a thrombolytic agent.
-11-
Blood activators
An appreciation of the importance of handling with¬
drawn blood by low temperature techniques (Fearnley et al.J
1952, Truelove 1953) and the development of more sensitive
assays have resulted in observations which are generally
interpreted as reasonable proof that trace amounts of
plasminogen activator are normally present in the plasma
of unstressed individuals (Fearnley and Lackner 1955,
Sherry et al . 1959*,,Flute I960). Enhanced fibrinolytic
activity, thought to be due to increased plasminogen acti-
vator, is associated with mental stress, exercise, adrena¬
line, ischaemia, shock, heat and pyrogens.
The source of plasma activator and the mechanisms
associated with enhancement will be discussed in a subse- !
quent section.
Activators of other body fluids
Plasminogen activators have been demonstrated in milk
(Astrup and Sterndorff 1952), tears (Storm 1955), saliva
(Albrechtsen and Thaysen 1955) and seminal fluid (Von
Kaulla 1953). The role, if any, of activators in these
fluids remains unexplored.
4. INHIBITORS




Naturally occurring activator inhibitors in plasma
have been postulated (Lewis and Ferguson 1951, JacobsSon
1955, Mullertz 1957, Flute I960, Paraskevas et al. 1962,
McNicol et al. 1963) but, as yet, the assay methods do not
preclude the possibility that they were not anti-plasmins.
Amino acid inhibitors
Following the earlier observation by Mullertz (1954)
that the amino acids lysine and ornithine inhibit plas¬
minogen activator, Okamoto (1954) demonstrated that the
potency of £ -aminocaproic acid (E.A.C.A.) was consider¬
ably greater. E.A.C.A. is a competitive inhibitor of
-4
activator at concentrations of 10 M and a non-competitive
I. -2
jinhibitor of plasmin at concentrations above 5 x 10 M
(Alkjaersig et al. 1959»; Ablondi et al. 1959). E.A.C.A.
|has been used clinically for some years now but may be
superseded by even more potent amino acids including
| |
:| -(aminomethyl) cyclohexane -4- carboxylic acid
(A.M.C.H.A.) and p-aminomethylbenzoic acid (P.A.M.B.A.).




Norman and Hill (1958) demonstrated an anti-plasmin
in the globulin fraction reacting quickly as a competi¬
tive inhibitor and another slow reactor appearing in the
fraction. More recent work by Moriau et al. (1964)
has confirmed these findings and further suggested that a
third anti-plasmin exists in the gamma fraction.
The physiological role of these inhibitors has hardly
been explored, but it is assumed they play an important
role in the control system which prevents excessive and
dangerous fibrinolysis. On the other hand, in the
presence of fibrin plasmin seems to favour inter-reaction
with it rather than with the anti-piasmins (Norman 1966).
Platelet anti-piasmins
Although Johnson and Schneider (1953) demonstrated
significant platelet anti-plasmin content this was not
confirmed by Dudok de Wit (1964). Despite this discre¬
pancy, platelet anti-plasmins may yet be shown to play an
important role in the resistance to lysis of the in vivo
thrombus.
Miscellaneous anti-piasmins
Several , apparent 1y unre1 ated, substances have been
shown to inhibit plasmin action: including basic amino
acids (Mullertz 1954), heparin (Von Kaulla and McDonald
1958), heavy metals (Kowalski et al. 1956), soya-bean
trypsin inhibitor (Christensen and Macleod 1945), E.A.C.A.
(Alkjaersig et al . 1959«) and Trasylol (Steichele and
Herschlein 1961).
B. PHYSIOLOGICAL CONSIDERATIONS
1 • IN VIVO FIBRINOLYSIS
Investigations of the fibrinolytic enzyme system in
vivo have posed many difficult problems, not least of
these being the very real deficiencies in methodology.
Also perplexing has been the problem of reconciling the
known protean actions of plasmin with the necessary speci¬
ficity for fibrinolysis in vivo. Furthermore, the appear¬
ance of an activator in plasma would produce a complex and
continuously changing state resulting from s imiil t aneous
reactions involving activation, inhibition and the diges¬
tion of multiple stis cept ibl e prot eins . Since under
normal physiological conditions anti-plasmin inhibitor is
present in considerable excess (as compared to avai 1 able
plasmin), it is considered unlikely that the fibrinolytic
process in man is controlled by the level of free plasmin
in the c i rc\il at i on: a view now supported by substantial
evidence (Sherry et al. 1959b, Alkjaersig et al . 1959b),
- 15 -
Sawyer et al. I960).
Rapid strides were made in understanding how this
enzyme system worked in vivo, following the work of
Fearnley ( 1953, 1961 ) and Sherry et al . (1959k), when it
was considered that plasminogen was deposited in signifi¬
cant amounts whenever a clot formed, that plasminogen
activator diffused into the clot and that the resultant
generation of plasmin within this fibrin meshwork could
be considered independent of the circulating plasma and
thus protected from the large quantities of circulating
anti-plasmins. This feature endows considerable speci¬
ficity to the fibrinolytic enzyme system, and allows
activation of small amounts of plasminogen within the
interstices of the thrombus, thus resulting in extensive
and protracted clot dissolution without other manifesta¬
tions of systemic proteolysis.
Two important factors are essential to this so-called
Sherry hypothesis: sufficient intra-clot plasminogen for
subsequent activation to plasmin, and the passage of
activator into the thrombus. Gross (1963), using iso-
topically labelled streptokinase, has demonstrated rapid
and deep penetration into the thrombus. The problem of
the plasminogen content of clots, however, is now more
controversial. Sherry's group (Sawyer et al. 1961)
observed that approximately 30% of the available plasmino¬
gen was adsorbed onto the fibrin during coagulation.
Neither Ogston et al. (1966) nor Hedner et al. (1966)
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have been able to confirm this observation, but the former
group consider plasminogen diffuses into the clot follow¬
ing coagulation.
An entirely different hypothesis for in vivo clot
lysis has been propounded by Ambrus and Markus (I960).
They envisaged a circulating p1asmin-anti-p1asmin complex
which provides a potent and readily available store of
plasmin. In the presence of fibrin the complex is split
and so releases the plasmin which is preferentially
attracted to fibrin. More recently Olesen (1965) has
combined the mechanisms of both theories and envisaged an
activator-anti-activat or complex which can be split at
local sites of fibrin deposition.
It is possible that these different hypotheses
relating to the mechanisms of physiological in vivo
thrombolysis may not prove to be mutually exclusive.
Whatever the final outcome, the Sherry hypothesis is now
almost universally accepted as a good working hypothesis
and thus under physiological circumstances thrombolysis
would appear to be regulated, at least in part, by the
availability of plasminogen activator.
2. SOURCE OF CIRCULATING PLASMINOGEN ACTIVATOR
Nolf (1904) first suggested that blood vessel walls
might be the source of fibrinolytic enzymes. More recent
observations by Kwaan and McFadzean (1956, 1957), Todd
< I
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(1959), Messer et al. (1962), Chakrabarti et al. (1963),
Kwaan and Astrup (1963) and Neri Serneri et al. (1965)
have confirmed, beyond reasonable doubt, that at least one
source of circulating plasminogen activator arises from
the intimal surface of veins, venules and capillaries.
WTiether tissue activator makes any contribution is more
controversial, although Maki et al. (1965) have suggested
mechanisms which would make this feasible.
3. CONTROL OF THE LEVEL OF CIRCULATING
PLASMINOGEN ACTIVATOR
Observations by many investigators have indicated
that the in vivo fibrinolytic mechanism appears to be
continuously active and quite dynamic in its response to
stimuli (Sherry et al. 1959k, Fearnley 1961, Von Kaulla
1963). The plasma of healthy adults normally contains
significant but small amounts of activator, but this can
be rapidly and strikingly increased by a variety of
physiological and pharmacological stimuli.
Despite the wide diversity of stimulating agents it
is possible that the release of circulating plasminogen
activator may be physiologically controlled by neurogenic
and/or humoral mechanisms. Kwaan and McFadzean (1956,
1957) first postulated a neurogenic effector control of
the intimal units. This work has been somewhat over¬
looked as it was based upon an incorrect assumption that
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venous occlusion had no effect on fibrinolytic activity
(Clarke et al. I960, Tighe and Swan 1963). Despite these
criticisms, recent investigators have again emphasised the
possibility of a neurogenic and/or humoral control of
plasminogen activator release (Schneck and Von Kaulla
1961) and Benetato et al. (1964) have provided interesting
evidence to support the hypothesis of a specific hypothala¬
mic area which controls the level of circulating plasmino¬
gen activator.
The final common mechanism for all these diverse
stimuli may prove to be adrenaline. Holemans (1965)
considered that the increased plasminogen activator
following all known fibrinolytic stimulating procedures
was secondary to vasoactive changes, so that resting areas
of the vascular bed were washed out, or that intimal units
were damaged following either anoxia (vasoconstriction) or
stretching (vasodilatation).
Equally important for the control of blood levels of
plasminogen activator are those for the subsequent removal
of this substance. It is now reasonably certain that the
liver plays an important role in the removal of at least
some of circulating plasminogen activator (Fletcher et al.
1964, Januszko et al . 1966).
4. FIBRINOLYSIS - COAGULATION EQUILIBRIUM
In 1908, Nolf proposed the existence of a dynamic
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equilibrium between fibrin deposition (coagulation) and
fibrin removal (fibrinolysis). This hypothesis received
the support of Copley (1954), Astrup (1956), Jensen (1956),
Witte (1958), Roos (1958), Fearnley (1961), Salmon (1961)
and Woolf (1961) and is envisaged in its fullest concept
as a continuous process, in which the endothelial lining
of vessel walls is coated with a thin layer of fibrin.
Iatridis and Ferguson (1962, 1966) have postulated that
the bridge between the two systems is Hageman Factor.
Despite the evidence in favour of this hypothesis,
there is a considerable quantity of equally conflicting
information (Gajewski and Alexander 1963, Kamel et al.
1963, Lewis 1963, Izak 1965, Lewis and Szeto 1965, Izak
and Gajewski 1966). It is not proposed to examine the
pros and cons for this hypothesis for, at present, it is
impossible to either prove or disprove (Hjort and Hassel-
back 1961). However, even if the main argument in favour
of this hypothesis is its obvious beauty, it has resulted
in a large amount of research endeavour to which the con¬
tribution outlined in this thesis must be added.
C. PATHOLOGICAL CONSIDERATIONS
1. FIBRINOLYSIS AND OCCLUSIVE VASCULAR DISEASE
Rokitansky, 100 years ago, was the first to propose
ithat deposits of fibrin on the arterial intimal wall
Icaused atherosclerosis. More recently this hypothesis
has been revived by Duguid (1949, 1955) whose observations
that fibrin can be deposited on arterial intima, covered
by endothelium and thus incorporated into the vessel wall,
lhave been partially confirmed by Harrison (1948), Hend
(1949), Crawford and Levene (1952) and Ambrus et al.
(1958). These findings have been extended by Astrup
j(1956) to relate them to the proposed coagulation -
fibrinolysis equilibrium so that excessive coagulation or
diminished fibrinolysis would result in excess intimal
fibrin which is later incorporated into the vessel wall.
If intravascular fibrin formation plays a role in
the development of atheroma, it follows that factors
operating to remove it are of major importance. The sub-j
sequent efforts of various groups of investigators to
^demonstrate defective fibrinolysis in occlusive vascular
disease has proved to be disappointing and controversial
: (Hume 1958, Nestel 1959, Lackner and Merskey I960, Merskey
et al. I960, Nestel I960, Goldrick 1961, Ogston 1962,
IFearnley et al. 1963, Katz et al. 1963, Naimi et al. 1963,
MacKay and Hume 1964). In a review of the recent litera-.
ture, Fearnley (1965) has concluded that there is little
evidence of a difference in blood fibrinolytic activity
between males with overt coronary artery disease and aged
matched controls, but there is some reason to suspect
■defective fibrinolysis is present in post-menopausal womenj
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iin women with ischaemic heart disease and in both sexes
suffering from peripheral atherosclerosis.
2. FIBRINOLYSIS AND CANCER
The interesting possibility that the spread of malig¬
nant tumours, both directly and met astatical1y, may be
governed by the ability of these cells to form and main¬
tain fibrin has been postulated by Wood (1958) and O'Meara
(1958). Cliffton (1966) has reported that the induction
'of an active fibrinolytic state, in animals given large
doses of intravenous cancer cells, markedly reduced the
^number of metastases even when large numbers of tumour
cells were shown to be present in the circulating blood.
The significance of these findings remains, as yet, un¬
resolved, but Thornes (1966) has recently emphasised that
I
an important factor in the spread of cancer may be the
ability of the cancer cell to maintain its fibrin in the
face of the opposing fibrinolysis in the host. Should
this hypothesis be confirmed then the activity of the
fibrinolytic system of the host may be a factor of major
significance. .Although Thornes (1966) has concentrated
!on the individual variation in the production of anti-
plasmins it may prove that the ability to generate plas¬
minogen activator is of equal importance.
.
3- FIBRINOLYSIS AND SHOCK
Innes and Sevitt (1964) have shown that during the
first few hours following severe injury there is a marked
acceleration of coagulation and fibrinolysis, followed by :
a fall to normal, but in some cases a fall well below
normal in fibrinolysis. Hardaway (1966) has postulated
I
that in many types of shock an important cause of a fatal
outcome may be the widespread thrombosis of the micro¬
circulation, thus leading to severe and irreversible
tissue anoxia. In the light of this hypothesis Hardaway •
!
has emphasised that situations of danger may arise if the
endogenous fibrinolytic response is either too little or
too late.
It is clear from the foregoing brief discussion of
the possible role of the fibrinolytic enzyme system in
occlusive vascular disease, spread of cancer and shock
that the studies are grossly incomplete. Further useful
information is unlikely to be obtained without either
prolonged and carefully controlled investigations or an
entirely fresh approach to the study of the physiological
control mechanisms of fibrinolysis.
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CHAPTER 2
HYPOTHESIS AND AIMS OF PROJECT
It is possible that some of the present uncertainty
concerning the role of the fibrinolytic enzyme system in
physiological and pathological situations arises from the
known fact that the resting level of blood fibrinolysis
can differ considerably between apparently healthy indi¬
viduals and may fluctuate in any one person, from day to
day, and throughout the same day (Fearnley 1959, Blix
1961). Most of the reported studies have been based upon
single observations, and, in this situation, unless ex-
treme and prolonged differences in fibrinolysis exist
between the disease states under investigation and the
normal controls, comparison by single estimations might
fail to yield satisfactory results.
Certain physiological situations such as exercise
(Biggs et al. 1947, Truelove 1951, Fearnley and Lackner
1955, Sherry et al . 1 959 bj Bi 11 imoria et al. 1959, Sawyer
et al. I960, Ogston and Fullerton 1961, Iatridis and
Ferguson 1963, Jange et al. 1964, Ogston and McAndrew 1964,
Burt et al. 1964) and mental anxiety (Macht 1952, Dreyfuss
1956, Friedman et al. 1958, Ogston et al. 1962) stimulate
'
an increase in both coagxilation and fibrinolysis (the
latter being due to plasminogen activator). Careful
analysis of t he exercis e s tudies reveals that some of the {
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.
subjects responded poorly. Those who have commented on
these poor responders have given tentative explanations.
Biggs et al. (1947) considered physical fitness relevant,
Sawyer et al. (I960) inappropriate timing of sample collec¬
tion, whereas Iatridis and Ferguson (1963) suggested that
r
a failure to show the usual reaction to stress may have
!occurred. In fact, it is impossible to make any satis¬
factory conclusions from these earlier studies because of
the variations in fibrinolytic assay techniques and the
types of exercise used in different laboratories. Of no
.
less importance is the fact that no attempt was made to
ascertain whether this phenomenon was reproducible.
It is proposed that the accumulation of single sample
absolute values of plasma fibrinolysis may be of limited
value, particularly in a system which is assumed to be in
a state of dynamic flux, and that attention should be
turned to the capacity of the organism to produce a
-
Fibrinolytic response to stressful situations. Thus,
evidence, if obtained, of a poor ability to generate
plasminogen activator to stress may be of more physio-
pathological significance than the measurement of absolute
resting values.
The following chapters describe the methods and
results of a series of studies designed to investigate
whether in a group of 50 apparently healthy young and
middle aged human subjects there exists a small proportion





SUBJECTS AND EXPERIMENTAL DESIGN
SUBJECTS
Two groups of volunteers were studied: 50 young
■
healthy subjects (25 male and 25 female) aged between
18-30 years (mean age: 22.3 years) and 50 healthy middle-
aged subjects (25 male and 25 female) aged between 42-57
iyears (mean age: 49.6 years).
All subjects were required to give a full medical
history and in addition the middle-aged subjects received
a medical examination which included:-
(1) Clinical examination of heart, peripheral
pulses, chest and abdomen.
(2) Measurement of resting (supine 15 minutes)
blood pressure (by auscultation).
(3) Urine analysis for sugar and albumin.
(4) Resting and post-exercise (2 minutes step-up
test) electrocardiography.
All experiments were performed between 9.00 a.m. -
12.00 noon after a light breakfast, in a procedure room at
|19-20J C. Subjects were requested to abstain from
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smoking and excessive exercise on the morning of the
experiment and, on arrival at the laboratory, were
required to rest, lying down, for 30 minutes.
All subjects undertook the fibrinolytic stimulating
procedures on more than one occasion. Most experiments
were repeated at weekly intervals, but a few at intervals
of several months. Nine of the young women, with a
history of regular and trouble-free menstrual cycles,
were studied at weekly intervals throughout a menstrual
cycle.
EXERCISE
Previous investigations on the effect of exercise on
fibrinolysis were not designed for a critical analysis of
the ability of subjects to generate plasminogen activator.
In the first instance some exercise procedures, by their
very nature, were impossible to standardise, such as
basketball (Sherry et al . 1959 Sawyer et al . I960),
walking over moors (Ogston and Fullerton 1961) and running!
up and down stairs (Macfarlane and Biggs 1947). Other
work in which exercise to exhaustion was used (Iatridis
and Ferguson 1963, Burt et al. 1964) must be criticised
because of fundamental problems of motivation and the pos¬
sible danger for older subjects.
Truett et al. (1966) have recently stressed the
practicabi1ity of submaximal exercise testing in
I
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epidemiological studies of coronary heart disease. The
type of the submaximal used in this study was based upon
o
the work of Astrand (1964). He emphasised certain
points, all of which were considered:-
(a) Great muscle groups should be engaged in the test work
thus avoiding local muscular fatigue being a limiting
factor.
(b) The work must be technically fairly easy so that
mechanical efficiency is kept relatively constant,
and the efficiency fairly high.
(c) The work load must be reproducible. (Apparatus which
best satisfy (b) and (c) are the treadmill and bicycle
ergometer.)
(d) Investigations should be made during a steady state,
i.e. four to five minutes or longer after the start of
the work.
(e) The work intensity should not be so high as to make
motivation play a dominating part.
(f) The work intensity should not be too low otherwise
psychological factors may influence the results.
The standard exercise procedure chosen was 8 minutes
on a treadmill at 3.4 m.p.h. with a 5° elevation. Cal¬
culating from the normogram of Workman and Armstrong
(1964) for predicting treadmill walking oxygen consumption,
the energy expenditure for this exercise was of the order
of 5K Cals/min., which has been classified by Christensen
(1953) as moderate exercise.
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A further attempt at improving reproducibility of the
exercise was made by requesting each subject to adjust his
stride to 120 paces/min. with the assistance of a metro¬
nome .
For the study of fibrinolytic reactivity to exercise,
the procedure was as follows: immediately following the
initial venepuncture, taken while at rest from a vein in
the cubital fossa, each subject was exercised. At the
termination of the 8 minute period the treadmill was
stopped, the subject requested to sit down and the post-
exercise blood sample withdrawn from a cubital vein in the
other arm.
ADRENALINL INFUSIONS
Biggs et al. (1947) first demonstrated the ability of
adrenaline to stimulate an in vivo increase in plasma
fibrinolytic activity in man. This observation has been
confirmed by others, including Truelove (1951), Kwaan et
al . (195$), Sherry et al . (1959»), Genton et al . (1961),
Doni et al. (1963) and Neri Serneri et al. (1965).
Most of the previous studies on adrenaline induced
fibrinolysis have used the subcutaneous route of adminis¬
tration. The many variable factors known to govern ad¬
sorption of subcutaneously administered drugs (Goodman and
Gilman 1965) precluded this route on the grounds of inade¬
quate reproducibility. For this reason, and those of
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safety, the intravenous route was used in the study of
generalised fibrinolytic reactivity to adrenaline.
Preliminary experiments, which will be discussed in
a subsequent chapter, demonstrated that a satisfactory
fibrinolytic response to intravenous adrenaline could be
achieved with a dose of the order of 10 pgm./min. for 2
minutes. A correction factor was applied to give a more
standardised dose by relating it to the body surface area.
Thus the precise dose administered, using a Harvard Con-
2
stant Infusion Pump, was 10 pgm./1.95 m surface area/min.
for 2 minutes in a total volume of 20 ml. normal saline.
The preparation of adrenaline used was that of Parke-
Davis (batch no. 35-11-1-16: each ml. contained 1 mg.
adrenaline as the hydrochloride dissolved in normal saline,
with 0.5% chlorbutol as a preservative). This adrenaline
preparation was kept at +4° C. and further diluted in nor¬
mal saline immediately before use. No further preserva¬
tive was added to the diluted adrenaline.
For the routine study of fibrinolytic reactivity to
intravenous adrenaline the procedure was as follows:
immediately following the 30 minute rest period, a 21 G.
needle was inserted into a cubital vein, without local
anaesthesia, a blood sample withdrawn (the "before sample"),
the syringe detached and a connection made to the 50 ml.
syringe in the Harvard Constant Infusion Pump by means of
an Anaesthesia Extension Set (Baxter: BR - 335). The
time from the withdrawal of the blood sample to the onset
- 30
of adrenaline infusion was 1 minute. At the end of the
infusion period the anaesthesia extension set was clamped
and 2 minutes after the end of the infusion a second blood
sample was withdrawn (the "after sample") from a cubital
vein in the opposite arm.
Electrocardiographic recordings were made before and
during the adrenaline infusion. The development of any
form of arrhythmia was regarded as an absolute indication
to stop the infusion immediately: on no occasion was this
necessary. Subjects were carefully briefed as to the
possible subjective symptoms arising during the adrenaline
infusion, and should they be unduly alarmed, then the in¬





MATERIALS AND ASSAY TECHNIQUES
^MATERIALS
Anticoagulant
Sodium citrate B.P. 3.8% (supplied by Boots Pure
Drug Co. Ltd.).
Buf fers
(a) Barbiturate buffer. Modified veronal buffer of
pH 7.5 and ionic strength 0.15 (Owren, 1947).
(b) Tris buffer. 0.15 M solution of tris-(hydroxy-
methyl)-amino-methane (Koch-Light Laboratories Ltd., Batch
No. 11342) adjusted to pH 7.8.
(c) Phosphate buffer. 0.1 M at pH 7.6.
*(Full details of composition of the various reagents usee






A Blomback and Blomback (1957) preparation of human
fibrinogen with a clottability of 97% (supplied by Kabi
Pharmaceutical Company, Batch No. 83164) was used. Ali¬
quots of a 1.5 g./lOO ml. solution of fibrinogen in tris
buffer were stored in plastic tubes at -20° C. After
thawing it was diluted to 0,15 g./lOO ml. in tris buffer
and used for fibrin plates.
Thrombin
Topical thrombin (Parke Davis and Co., Batch No.
03179A) was used. A solution of 50 units/ml. in tris
buffer was prepared for fibrin plates, one of 5 units/ml.
in barbiturate buffer for euglobulin lysis time estima¬
tions, and one of 100 units/ml. in physiological saline
for fibrinogen estimations. Aliquots of all these solu¬
tions were stored at -20° C. in plastic tubes and used
immediately after thawing.
St rept okinase
The preparation produced by Lederle Laboratories
(Batch No. 2201-66) was used for plasminogen assays. It
was diluted to 2,000 units/ml. in phosphate buffer and
aliquots stored in plastic tubes at -20° C.
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Urokinase
The standard reference preparation (2,400 Plough
units) produced by Leo Pharmaceuticals, Denmark (Batch No.
63062) was used. Solutions of 3 units/ml. in tris buffer
were prepared and aliquots stored at -20° C. in plastic
tubes.
Casein
The preparation produced by L. Light and Co. Ltd. wats
(Batch No. 5051).
Glassware
All glassware was siliconised by means of a 3% solu¬
tion of I.C.I. M550 silicone in trichlorethy1ene.
Petri dishes
Plastic petri dishes with an internal diameter 8.8 cm.
(supplied by Staynes Laboratories) were used. Each petri
dish was discarded after use.
Glass beads
0.15 mm. diameter: supplied by the English Glass
Company, Leicester.
- 34 -
ASSAY TECHNIQUES (excluding euglobulin lysis time assay)
Fibrinogen assay
A modification of the original method of Ratnoff and
Menzie (1951) was used. In this assay the fibrinogen is
clotted with thrombin and left overnight to ensure com¬
plete coagulation in a medium containing sufficient
E.A.C.A. to prevent further proteolysis. The tyrosine
released from the fibrin by hydrolysis with sodium hydrox¬
ide is estimated with Folin Ciocalteu's reagent. A
standard proportion of tyrosine in the fibrinogen/fibrin
molecule is assumed.
All assays were performed in triplicate in unsilicon-
ised 5" x 5/8" test tubes. Reagents were added in this
order: 6.0 ml. 0.85% saline-E.A.C.A. solution, 0.1 ml.
thrombin solution (100 units/ml. in 0,85% saline), 0.2 ml.
2.5% calcium chloride and 0.2 ml. of test substance
(plasma or euglobulin solution). The contents were mixed
by shaking and left to clot overnight at + 4° C. After
overnight clotting approximately 0.5 ml. of glass beads
(diameter 0.15 mm.) was added, the tube shaken and centri-
fuged at 3,000 r.p.m. for 2 minutes. The supernatant was
sucked off and discarded, an equivalent volume of 0.85%
saline added, the tube shaken and centrifuged as before.
This washing procedure with saline was repeated three
times. After the last removal of the saline, 0.4 ml. of
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10% sodium hydroxide was added and the solution boiled in
a water-bath for 20 minutes. The tube was then cooled
under tap water and 0.6 ml. 5% trichloracetic acid added,
followed by 2 ml. 0.5N sodium hydroxide and 0.6 ml. (1 : 2
diluted) Folin Ciocalteu's reagent. The contents were
mixed and 15 minutes later the colour intensity was read
at 650 mp against a reagent blank on a Unicam S.P.600.
The fibrinogen concentration was calculated from a standard
tyrosine curve and these readings were converted to fibrin¬
ogen by multiplying by 11.7. The mean difference between
triplicate observations over a wide range of fibrinogen
levels, expressed as a percentage of the mean of these
observations, was 6.2% - 0.45.
Plasminogen assay
The caseinolytic assay of Remmert and Cohen (1949) as
modified by Alkjaersig et al. (1959fc)was used. Anti-
plasmin was first destroyed by incubating the plasma with
-
acid. The acid is neutralised with alkali and buffer
and streptokinase is then added to convert the plasminogen
to plasmin, which is assayed by caseinolytic assay: the
amount of tyrosine released from the casein being a
measure of the amount of plasmin present.
All assays were performed in triplicate in 5" x 5/8"
unsi1iconised test-tubes. 0.5 ml. of test substance
(plasma or euglobulin solution) was added to 0.5 ml. N/6
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HC1 and left at room temperature for 15 minutes. 0.5 ml.
N/6 NaOH was then added, followed by 1 ml. phosphate
buffer (0.1M), and 0.5 ml. streptokinase (2,000 units/ml.
in phosphate buffer, 0.1M). After mixing, 2 ml. were
withdrawn and transferred to a test-tube containing 2 ml.
10% trichloracetic acid. The remaining 3 ml. in the
original test-tube were incubated for 60 minutes at 37° C.
in a water-bath and the 3 ml. 10% trichloracetic acid were
added. The pre- and post-incubation samples were then
centrifuged at 3,000 r.p.m. for 2 minutes and the super¬
natant filtered by gravity through a Whatman's No. 1 filter
paper. 1 ml. aliquots of the respective filtrates were
then transferred to a test-tube containing 5 ml. 0.5N NaOH
and 1.5 ml. 5% trichloracetic acid. To this mixture
1.5 ml. Folin Ciocalteu's reagent (diluted 1 : 2) were
added. After 15 minutes at room temperature the optical
density was read on a Unicam S.P.600 at 650 mp, reading
the pre-incubation sample against the 60 minutes incubation
sample. The milligrams of tyrosine released were calcu¬
lated from a standard curve, and one casein unit equalled
180 pg. tyrosine released in one hour. The mean percent¬
age error over a wide range of normal values was 2.5% -
0.31.
Fibrin plates
TJnheated human fibrin plates were prepared by a
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modification of the method of Astrup and Mullertz (1952).
(This was regarded as a semi-quantitative measure of
plasminogen activator). 10 ml. of 0.15G% fibrinogen in
tris buffer were pipetted into a plastic petri dish and
7
clotted immediately with 0.2 ml. thrombin solution on a
level table. Twenty minutes after the addition of throm¬
bin, to ensure complete clotting, 0.03 ml. samples of the
test material, in triplicate, were dropped onto the fibrin
films. The plates were incubated at 37° C. for 24 hours
and the products of the perpendicular diameters taken as
a measure of fibrinolytic activity. Sensitivity of the
plates prepared each day was checked by observing the
area of lysis after drops of urokinase (3.0 units/ml.)
were added. The mean percentage error of this method was
12.4% - 0.61.
E.A.C.A. human fibrin plates were used in some
studies for plasmin assay (McNicol and Dougl as Milf). Standard
human fibrin plates were prepared but before clotting 1 ml.
of E.A.C.A. (10 M) in tris buffer was added and thorough¬
ly mixed.
Urokinase inhibitor assay
Urokinase inhibitor assays were based on the method
of Blix (1964). The test material was incorporated in
the fibrin film and the degree of inhibition compared
against the control. Human fibrin plates were prepared
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as above, but before clotting 1 ml. of euglobulin solution,
diluted in saline (0.85%), v/as added and thoroughly mixed.
A series of four plates was used containing dilutions of
TU' T5' *5^ anc* a contr°l with 1 ml. saline. 0.03 ml.
drops of urokinase (3.0 units/ml. in tris buffer) were




EUGLOBULIN LYSIS TIME ASSAY
Hedin (1904) first demonstrated the presence of a
weak proteolytic enzyme in serum by precipitation of the
globulins. This observation was later extended by
Milstone (1941) and Macfarlane and Pilling (1946) and this
technique is now generally regarded as a sensitive and
useful one for the assay of uninhibited plasma plasminogen
activator (Sawyer et al. I960, Iatridis and Ferguson 1963,
Fletcher et al. 1964, Moser and Hajjar 1966). By suit¬
able dilution of the plasma and adjustment of pH using
diluted acetic acid (Milstone 1941) or CC^ (Von Kaulla and
Schultz 1958) a euglobulin precipitate is formed, the con¬
tents of which include plasminogen activator, plasminogen
and fibrinogen. The precipitate is collected, removed
from the supernatant (which contains the anti-fibrinolytic
substances (Blix 1964)), resuspended in a buffer and
clotted with thrombin. The time required for complete
lysis, from the addition of thrombin, is taken as the
euglobulin lysis time. The time is inversely related to
the level of plasminogen activator.
Although this assay procedure is basically simple to !
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execute it is fraught with theoretical and practical diffi
culties (Blix 1961). In view of this fact, and that it
represented a central part in the assessment of fibrino¬
lytic reactivity in the subsequent studies, it was felt
necessary to carry out certain studies in an effort to
obtain a satisfactory standardised procedure.
There are four major factors which have been regarded
as influencing the euglobulin lysis time: substrate
variability, blood withdrawal and subsequent handling,
and euglobulin fraction preparation and end-point record¬
ing.
Substrate Variability
The major components in the euglobulin fraction,
which are of interest from the fibrinolytic point of view,
are plasminogen activator, plasminogen and fibrinogen.
An apparent disadvantage of this method is that these sub¬
strates are supplied in this clot lysis system from the
subject under study and therefore normal variations in
plasma plasminogen and fibrinogen may affect the results
to an unknown extent (Kowalski et al. 1959, Blix 1961,
Fearnley 1965).
This problem was studied by measuring the euglobulin
lysis time and the euglobulin content of plasminogen and
fibrinogen in a series of 33 subjects. Fig. 2 shows a
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FIG.2 EUGLOBULIN PLASMINOGEN AND FIBRINOGEN PLOTTED AGAINST THE
E0GL0B0LIN LYSIS TIME.
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correlation between the individual substrates and the
euglobulin lysis time. These results would seem to indi¬
cate that the euglobulin lysis time is a valid measurement
of plasminogen activator and are in agreement with the
results and conclusions of Fletcher et al, (1964} and
Moser and Hajjar (1966).
Blood Withdrawal and Subsequent Handling
(a) Venous occlusion
Venous occlusion has been demonstrated to increase
the blood fibrinolytic activity in the occluded arm
(Clarke et al. I960, Holemans 1963, Iatridis et al. 1966),
and Ata et al, (1964) have stressed the importance of the
strictest attention being paid to the venepuncture tech¬
nique in fibrinolytic investigations. The work of Tighe
and Swan (1963), however, would suggest that as much as
2 minutes occlusion is required to demonstrate this effect
On the basis of these findings venous occlusion was per¬
mitted for no longer than 30 seconds for all studies
reported in this thesis,
(b) Deterioration effects due to delayed assay procedures
Loss of fibrinolytic activity, of withdrawn blood,
due to delayed assay procedures was first stressed by
Fearnley et al. (1952) and Truelove (1953) and more
recently by Januszko et al. (1965). A small series of
43 -
experiments was therefore undertaken to assess the practi¬
cal limit of this problem.
45 ml. of fresh blood were added to 5 ml. pre-cooled
anticoagulant, thoroughly mixed and placed in a bath of
melting ice. 5 ml. aliquots were poured into a pre-
cooled siliconised centrifuge tube at regular intervals
and immediately centrifuged for subsequent assay of the
euglobulin lysis time. The results are shown in Fig. 3
and clearly confirm the previous work, but do show that
little or no deterioration occurs if the blood is proces¬
sed within 15 minutes of withdrawal. Accordingly, in all
subsequent experiments blood was centrifuged within 15
minutes of withdrawal.
(c) Low temperature blood handling
Fig. 3 also confirms the findings of Fearnley et al.
(1952) and Truelove (1953) that the stability of blood
plasminogen activator is enhanced by a low temperature
technique. Accordingly, all procedures, once the blood
samples were withdrawn, were performed at +4° C.
(d) Glass contact effects
According to Flute (I960) an anti-activator, which is
precipitated in the euglobulin fraction, is generated when
blood comes into contact with glass. No attempt has been
made to confirm this observation but all glassware used
was thoroughly siliconised (full details of the technique
- 44
100 n








15 30 45 60 75 90
TIME (mins) OF STORAGE
Fig.3. Deterioration effects on the euglobutin lysis time of
blood left standing at*4*C and room temperature (*20*0
(mean of 5 experiments)
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are recorded in the Appendix).
(e) Cent rifugation
There is evidence that platelets contain anti-plasmin
(Alkjaersig 1961, Holemans and Gross 1961) and proactiva-
tor (Greig and Cornelius 1961) activity. In order to
avoid this variable source of error euglobulin fraction
was precipitated from platelet poor plasma according to
Iatridis and Ferguson (1963).
Euglobulin Fraction Preparation
In an excellent study of the problems of euglobulin
precipitation, Blix (1961) clearly demonstrated that a
most critical factor affecting the fibrinolytic activity
of the euglobulin fraction was the pH at which it was
precipitated. The following experiments were performed
in order to confirm and extend these findings, to assess
their significance to the euglobulin lysis time method as
applied to the subsequent studies on fibrinolytic reac¬
tivity and to adjust the method accordingly.
Eug.lobulin fractions were precipitated by adding
plasma from one subject to dilute acetic acid, in propor¬
tions of 1 : 9 respectively. The dilute acetic acid
concentrations were so arranged that the final pH range
varied from 5.0 - 6.4. Assays on the resultant euglobu¬
lin fractions were made of the euglobulin lysis times,
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area of lysis on standard human fibrin plates and E.A.C.A.-
jfibrin plates, plasminogen, fibrinogen and inhibitor con-
tent. The results are arranged in Table 1 and confirm
the findings of Astrup and Rasmussen (1958) and B1ix
(1961) that maximum yield of plasminogen activator, with¬
out spontaneous autocatalytic activation of plasminogen,
is obtained at a pH of approximately 6.0. The results
also indicate that any variation in the pH of euglobulin
precipitation will affect the resultant euglobulin lysis
t i me .,
In the light of these findings further studies were
made to determine whether using fixed volumes of dilute
.
acid provided satisfactorily reproducible pH levels
between individuals. Triplicate samples of euglobulin
suspensions were made from fresh plasma samples obtained,
almost simultaneously, from 15 healthy subjects. The pH
of these suspensions was then determined using a Beckman
Expanded Scale pH Meter.
The results, shown in Table 2, demonstrate that the
j
range of final pH was between 5.58 - 5.78. Part of this
variation may be due to the variability in the buffering
jpower of plasma (Salenius 1957). The importance of this
finding is that individual variations in the euglobulin
lysis time, using pre-set quantities of dilute acetic acid
(may be partially due to variation in the pH at which the
euglobulin fraction is precipitated. Subsequent studies
on fibrinolytic reactivity therefore took these results
TABLG 1
4k r-U(-
35IK EFFECTS OP PRECIPITATING THE E0GL0B3LIN FRACTION AT DIFFERENT TEb
Area of. Area of. Inhibitor AssjW
Sii"K -1 £»/•»■♦• ; ^**1 n4 "f"O "4"*1 AY1 Euglobulin Lysis (nun ) Lysis (mm ) Guglobulin Luglobulin Plasma Plasma (Area in m.in.'0WUL/J CV# w
Mr*
^ JLv»wi^v/JU UuiwXC/Ii
v>ll Lysis Time on Standard on E.A.C.A. Fibrinogen plasminogen Fibrinogen PlasminogenHO • pit (mins.) Human Fibrin Fibrin (mg./lOO ml.) (c.u./ml.) (mg./lOO ml.) (c.u./ml.) Euglobulin Dilution Saline
Plates Plates 1 1 1
Control
10 5025
5.0 16 350 0 214 3.89
5.2 242 340 0 264 4.24 440 410 414
1 5.6 226 342 0 262 4.28 (440) (4.31) (400)
6*0 193 380 0 244 4.I8 424 400 422
6*4 114 484 49 192 3.76
5.0 84 504 0 172 2.94
5.2 117 484 0 194 3.46 396 396 384
2 5.6 108 496 0 188 3.49 (364) (3.25) (388)
6*0 73 566 0 168 3.30 396 388 384
6.4 44 614 25 148 2.04
5.0 620 225 0 106 4.05
5.2 820 210 0 152 5.21 424 424 416
3 5.6 734 210 0 178 5.18 (262) (5.44) (416)
6.0 615 232 0 149 5.00 424 424 410
6.4 300 294 25 102 4.96
5.0 345 314 0 85 3.92
5.2 450 248 0 117 4.24 400 400 400
(410)4 5.6 380 278 0 160 4.28 (202) (4.29)
6.0 240 348 0 140 4.14 410 414 400
t
6.4 175 398 49 130 3.98
TABLE 2
THE pH OP ELGLOBULIN SUSPENSIONS OP 15 HEALTH! SUBJECTS
Subj. No. pH of triplicate samples
Mean
pH
1 5.66 5.64 5.66 5.65
2 5.73 5.70 5.73 5.73
3 5.69 5.69 5.69 5.69
4 5.65 5.64 5.64 5.64
5 5.66 5.67 5.68 5.67
6 5.64 5.64 5.66 5.64
7 5.75 5.75 5.79 5.78
8 5.60 5.63 5*61 5.62
9 5.64 5.62 5.64 5.63
10 5.66 5.67 5.68 5.67
11 5.63 5.63 5.64 5.63
12 5.59 5.68 5.64 5.60
13 5.60 5.62 5.68 5.63
34 5.59 5.58 5.58 5.58
15 ; 5.68 5.69 5.69 5.68
.Range 5.58 - 5.78
Euglobulin was precipitated from 1 ml. of plasma in 19 rals. of
distilled water to which 0.18 ml. of acetic acid had previously
been added.
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into account by precipitating all euglobulin fractions, by
careful titration, to pH 6.0. Because of this critical
pH control, dilute acetic acid was preferred to the CC>2
method of Von Kaulla and Schultz (1958).
Comment
Although the purpose of these studies was not an
exhaustive examination of euglobulin preparation, suffici¬
ent information was obtained which answered the questions
originally posed. Accordingly, the following techniques
for the euglobulin lysis time were undertaken and rigidly
adhered to during the experiments described in subsequent
sections.
1. Blood sampling and centrifugation
9 ml. of blood were withdrawn by clean venepuncture,
with the minimum of venous occlusion (less than 30 seconds],
into a siliconised syringe. The blood was immediately
transferred to a previously cooled centrifuge tube, housed
in a receptacle of melting ice, containing 1 ml. of anti¬
coagulant. The centrifuge tube was covered with parafilm,
inverted twice and returned to the melting ice where it
remained until the second sample was obtained. Following
mixing, both were centrifuged at 3,400 r.p.m. (2,000 g.)
at +4° C. for 20 minutes. Immediately after, the upper
third of the plasma was removed, using a siliconised
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pasteur pipette, into a pre-cooled plastic tube. Subse¬
quent handling of the plasma, such as euglobulin precipi¬
tation and placing plasma drops onto unheated fibrin
plates, was done immediately.
2. Euglobulin lysis time assay
1 ml. of plasma was transferred to a siliconised
.
centrifuge tube in melting ice, containing 19 ml. of dis- !
tilled water and 0.18 ml. of 1% acetic acid. The pH was
finally adjusted to 6.0, on a Beckman Zeromatic pH meter,
0.25% acetic acid being used. Precipitation time was 10
minutes from the addition of the plasma and was done in
melting ice. The euglobulin suspensions were then centri-
fuged at 3,400 r.p.m. for 20 minutes at +4° C. The super¬
natant was discarded, the inside of the centrifuge tube
wiped dry with a tissue, and the precipitate resuspended
in 1 ml. of barbiturate buffer pH 7.4. 0.24 ml. of this
euglobulin solution was transferred, in triplicate, to 3"
by 3/8" (7. 5tmhy 1 cm.) siliconised test-tubes and 0.24 ml.
of thrombin solution (5 units/ml. in barbiturate buffer
pH 7.4) added immediately. The test-tubes were placed in
a water-bath at 37° C. and the time taken from the addi¬
tion of thrombin to complete lysis was recorded as the
euglobulin lysis time.
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End-point Recording : The Development of a
12 Channel Automatic Euglobulin Clot Lysis Recorder
An important source of error in the euglobulin lysis
time is the determination of the end-point of clot lysis,
which is normally done visually (Baumgarten et al. I960).
This subjective assessment of clot lysis has proved to be
inadequate on the grounds of reproducible accuracy objectir
.
vity and the uneconomic use of the laboratory worker's
time. A fully automatic device capable of determining
the lysis end-point of 12 euglobulin clots simultaneously,
with good reproducibility and accuracy, will now be des¬
cribed. This machine has been developed and built under
the guidance of the author by members of staff of the
Edinburgh University Department of Medical Physics, and
has been used in all the studies on fibrinolytic reactivity
in the middle-aged group of volunteers and most of the
physiological st\idies related to adrenaline infusions.
(1 ) Principles of operation
The operational principles of this machine are not
new and follow the basic concepts of other photoelectric
methods of recording coagulation and clot lysis (Nygaard
1941, Harrower 1962, Kuhnke and Tettenborn 1963, Nanninga
et al. 1964, Newman 1964). Light is shone through an
opaque clot and the amount transmitted is recorded on a
photoelectric cell, the output of which is recorded on a
- 50 -
direct-writing recorder. As clot lysis progresses in¬
creased light passes to the photoelectric cell until no
further change occurs when lysis is completed. The
euglobulin lysis time is taken as the time interval from
the addition to the point on the chart when no further
change takes place.
(2) Design
(a) Lysis Chamber (Castle), Fig. 4a, 4b and 4c
The Castle comprises a solid copper block (thermal
conductivity 0.918 CAL/sq. cm./° C.) into which holes were
machined to accommodate the various components and light
paths. A heating element, housed in the block, maintained
the temperature at 37° C. by means of a temperature sensing
and controlling system. Insulation was found to be un¬
necessary: standing on a bench at room temperature (20° C.
its temperature was maintained at 37° C. with a differen¬
tial of only 0.2° C. A common light source was used to
illuminate all sample tubes, the photocells being located
radially about this source. The provision of a single
light source for 12 clots assured electrical uniformity of
the 12 channels.
(b) Control unit, Fig. 5
Each photocell was fed to its appropriate bridge net¬

















TWO PIN SOCKET TO
-HEATER SUPPLY.
POLARISED
Fig, 4a. A diagrammatic representation
of the copper Castle.
- 52 -
Fig. 4b. The components of the copper
Castle viewed from above.
- 53 -
Fig. 4c. The components of the copper
Castle viewed from below.
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bridge, enabled the trace for each clot to be adjusted to
any required position on the chart paper. This arrange¬
ment greatly facilitated easy operation of the apparatus
and permitted its use by a technician after no more than
5 minutes' instruction.
(c ) Recorder
The outputs from the bridges were coupled to a Leeds
and Northrup 'Cleretrend' 12 point recorder, provision
being made for matching the photocell outputs. The
recorder selected each channel in turn and printed a dot
corresponding to the deflection from that channel. With
a paper speed of 3" per hour the resultant trace is a con¬
tinuous line. Channel identification is by colour and
number.
A photograph of the complete assembly is shown in
Fig. 6.
(3) Operational characteristics
Fig. 7 is a typical example of an actual chart record
of the lysis of 2 sets of 6 identical clots and shows the
good reproducibility between channels. (The clots were
transferred from a water-bath at 37° C. to the Castle 80
minutes after the addition of thrombin.) Table 3 records
the lysis times of a series of clots, obtained by the
visual and automatic methods. These results were recorded
- 56 -
Fig. 6. The complete assembly.
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Fig. 7. A photographic reproduction of an actual
chart record of the lysis of 2 sets of 6
identical clots.
TABLE 3
COMPARISONS OP THE EUGLOBULIN LYSIS TIKES RECORDED
VISUALLY AND BY THE AUTOMATIC CLOT LYSIS RECORDER
Sample
No.
Mean Suglobulin Lysis Time (ndns.)












in a blind fashion: the operator observing the clot lysis
visually was not allowed to see the clot lysis recorder,
and the clot lysis charts were read by an independent ob¬
server. There was no statistically significant differ¬
ence between both sets of readings ( 0. 3^.p<0. 4 ).
Comment
It is believed that this machine represents an impor¬
tant advance in the field of fibrinolysis research, for it
has achieved a degree of accuracy, reliability and objecti¬
vity seldom realised by the visual methods. Its large
capacity, which could be greatly increased, makes it an
attractive instrument for those engaged in population
studies and others requiring serial samples. Facilities
are also available for the output from any channel to be
recorded on other instruments. This means that it can be
readily adapted for other clot lysis systems and those
studies related to automatic coagulation end-point record¬
ing.
The collective reproducibility of the visual method
among four different workers in the laboratory, expressed
as a mean percentage error over a wide range of normal
values, where the euglobulin clot preparation was perfor¬
med by one person, as described in the previous section,
was 10.5% - 1.2. The mean percentage error for the auto¬





RESTING AND MODERATE EXERCISE
STUDIES IN 50 YOUNG SUBJECTS
1. Resting levels of euglobulin lysis time
Table 4 shows the results of all experiments. The
resting level of circulating plasminogen activator, as
measured by the euglobulin lysis time, varied from subject
to subject (range 68-502 min., mean: 183 min., standard
deviation 100 min.) and from day to day in some subjects.
No urokinase inhibitor content was demonstrated in the
euglobulin solutions studied (50 samples taken over a wide
range of euglobulin lysis times). The female group had
a significantly higher mean level of plasma plasminogen
activator than the male group ( 0. 001^»p«c.0. 01 ) , but there
were no consistent changes related to the phases of the
menstrual cycle in the 9 women studied.
Comment
The finding that, even under carefully standardised
assay procedures, the resting euglobulin lysis times
varied from subject to subject and from day to day in some!
S°f-
TABLE A
EUGLOBULIN LYSIS TIME BEFORE AND AFTER MODERATE EXERCISE
IN MALE AND FEMALE SUBJECTS AGED 18 TO 30 YEARS





















































































































































































+Cigarette smokers ( 10/day)
*Results during menstruation



























































































































































































































^Cigarette smokers ( 10/day)
^Results during menstruation






















































































































































































+Cigarette smokers ( 10/day)
♦Results during menstruation
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subjects confirms the observations of Blix (1961). In
view of the results, discussed previously (see Fig. 2),
demonstrating the absence of a correlation of euglobulin
substrate content and euglobulin lysis time and the
absence of detectable anti-urokinase in euglobulin frac¬
tions, it was concluded that there was insufficient evi¬
dence to preclude the probability that individual differ¬
ences in resting level of plasma plasminogen activator do
in fact exist. Furthermore, it would appear that it may
fluctuate widely in some individuals, as was suggested by
Fearnley (1961). These findings once again emphasise the
danger of overjs impl i f i cat i on in the interpretation of
fibrinolytic studies based on single estimations.
The observation of a statistically significant higher
level of circulating plasminogen activator in the female
group compared to the men is contrary to the findings of
Beller et al. (1964) and Brakman et al. (1966). It is
not possible, at present, to be certain of an explanation
for this apparent discrepancy but two factors may prove to
be relevant. Previous conclusions were reached, in the
main, from single observations: the possible misinterpre¬
tation of such observations has already been discussed.
Another probable reason for the marked sex difference in
base lines in the present work may have been the hetero¬
geneous nature of the two groups with respect to cigarette
smoking. There is fragmentary evidence to indicate that
■
cigarette smoking may have a deleterious effect on blood
- 61 -
fibrinolysis (^ibelli et al. 1964, Sogani and Joshi 1965).
Although this feature was not the subject of any specific
studies in this project, it was interesting to note that
when the cigarette smokers (more than 10/day) v/ere removed
from both groups (6 males and 1 female), and the remaining
19 males and 24 females compared, there was no statisti¬
cally significant difference in resting levels of plasmino¬
gen activator between these groups ( 0. 3.>p<C.0. 4) .
The finding of no consistent changes in the resting
level of plasminogen activator during a normal menstrual
cycle is contrary to the earlier observations of Smith and
Smith (1945) and Will son and Munnell (1946) but in agree¬
ment with the more recent observations of Seller et al.
(1964), Rao (1964), Brakman et al. (1966) and Menon (1966),
2. Exercise studies
{a) Pattern of fibrinolytic response
Fig. 8 shows the pattern of fibrinolytic response to
the standard exercise procedure. Serial cubital venous
blood samples were obtained by separate venepunctures
before, during and after the exercise and the euglobulin
lysis times recorded. The results demonstrated that the
I
maximum fibrinolytic response occurred at the termination
of the exercise. Based on these findings, subsequent
routine studies on fibrinolytic reactivity to exercise
were performed by simply comparing the euglobulin lysis
- 62 -
TIME (mins.)
Fig.8. The pattern of fibrinolytic response to the standard
exercise procedure.(Mean of 10 subjects)
- 63 -
times of blood samples obtained immediately before and
after the exercise.
(b) Fibrinolytic response in young subjects
If A and B represent the resting and post-exercise
euglobulin lysis times, respectively, the percentage res¬
ponse following exercise was calculated as A-B/^ x 100.xV
The results of this calculation for each experiment and
the mean percentage response for each subject are shown in
Table 4. These results would indicate that for any one
subject the fibrinolytic response was reproducible
(correlation coefficient r = 0.9929 and p<,0.001).
Furthermore, there was a highly significant individual
variation in response (analysis of variance showed F =
36.7, which was significant at the 1% level). Fig. 9
demonstrates the frequency distribution of the percentage
response in all subjects whereas Fig. 10 represents the
distribution when the sexes are separated. Statistical
analysis by the students * t• test showed a significantly
higher level of response in the females compared to the
males ( 0. 001>p< 0. 01 ).
There appeared to be no consistent changes in the
fibrinolytic response to the moderate exercise procedure
throughout the menstrual cycle.
Comment
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FIG.io.FREQUENCY DISTRIBUTION OF PERCENT RESPONSE TO MODERATE EXERCISE
IN MALES AND FEMALES.
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plasminogen activator level the fibrinolytic response,
expressed as a percentage of the pre-exercise level, in
normal young subjects was found to be a reproducible
phenomenon. There appeared to be significant differences
in response between individuals and it was possible to
isolate a group of poor responders. Of no less interest
was the finding that females of the same age-group had a
greater fibrinolytic response than males, and that in the
25 females studied no poor responder was demonstrated.
However, the fibrinolytic response was not influenced by
the various phases of the menstrual cycle.
Although the fibrinolytic response to exercise is
believed to be due to increased levels of circulating
plasminogen activator (Sherry et a 1.4., 1959 cl, I atr idi s and
Ferguson 1963), and although euglobulin plasminogen and
fibrinogen concentrations are not related to resting
levels of the euglobulin lysis time, it is nevertheless
possible that changes occurred in these substrates which
could account for the individual variation in fibrinolytic
responses to the standard exercise. This problem was
studied in 21 subjects in whom euglobulin plasminogen and
fibrinogen were estimated before and after the exercise.
There was a consistent small increase in both substrates
following exercise. However, when the percentage mean
post-exercise increase in both these substrates was
plotted against the percentage euglobulin lysis time res¬
ponse (Fig. 11), then no correlation was observed
- 67 -
10 20 30 10 50 60 70
PERCENT INCREASE IN EUGLOBULIN LYSIS TIME
Fig.11. Percentage post-exercise increase in euglobulin
substrates plotted against the percentage
increase in the euglobulin lysis time.
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(r = 0.024 : 0. 1 0.2 for fibrinogen and r = 0. 397 :
0.05.>p<0.1 for plasminogen).
It is possible that the variation in response between
individuals may simply mirror the individual variation in
stress to the exercise. If pulse rate response is a
measure of the exercise stress, then the absence of a
correlation between mean fibrinolytic response and mean
pulse rate response in the 22 subjects studied (Fig. 12;
r = 0.112 : p^.0,1) would not support this view. When
the two sexes were compared (Table 5), however, the posi¬
tion was less clear: the higher mean fibrinolytic res¬
ponse in the females was associated with a significantly
higher mean pulse rate response (males 70/min., females
84/min. , p<0.001). This latter finding is in agreement
O
with the work of Astrand (1952), who considered that the
cause of a higher female pulse rate response might be a
stronger distaste in women for physical exertion, or that
men might be more efficient working machines. Thus on
the basis of these findings alone, the sex difference in
fibrinolytic response in favour of the females could prove
to be due to the increased effort in this group.
Severe exercise has been shown to increase body tem¬
perature variably in different individuals (Holmgren and
Mcllroy 1964) and severe heat stress increases plasma
fibrinolytic activity (Bedrak et al. 1963). Although at
present no data are available which might elucidate this
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FIG.iaPERCENT INCREASE IN EUGLOBULIN LYSIS TIME PLOTTED
AGAINST INCREASE IN HEART RATE .FOLLOWING
MODERATE EXERCISE.
TABLE 5
THE MEAN PERCENT RESPONSE IN EUGL03ULIN LYSIS TIMS
AND PULSE RATE INCREASE FOLLOWING- MODERATE EXERCISE




















M 1 49 75 - 152 + 77 1 1 1 54 63 - 349 + 86
M 2 55 59 - 120 + 61 F 2 39 60 - 130 + 70
M 3 43 85 - 150 + 65 F 4 65 80 - 160 + 80
M 4 29 71 - 1A8 + 77 F 7 52 73 - 161 + 88
M 5 37 62 - 136 + 74 ! F 8 64 72 - 161 + 89
M 8 24 83-148 + 65 F 9 53 63 - 159 + 96
M 12 26 71 - 138 + 67 F 10 48 71 - 165 + 94
M 13 52 71-142 + 71 F 13 52 67 - 154 + 87
M 14 50 69 - 136 + 67 F 15 51 81-148 + 67
M 15 54 72 - 124 + 52
Mean - 84
M 16 38 84 - 156 + 72
X 17 14 60 - 143 + 83
M 21 24 51 - 136 + 85
Moan =70
70 -
regarded as unlikely that the exercise procedure used in
this work was sufficient to produce significant changes in
core temperature which are assumed necessary to cause in¬
creased fibrinolysis.
It was not possible to explain the poor responders
on the basis of physical fitness (Biggs et al. 1947).
Four of the young subjects studied were highly trained
athletes whose mean response ranged from 24 - 54%.
Iatridis and Ferguson (1963) demonstrated the generation
of a fibrinolytic inhibitor following exercise in one of
their poor responders. Using the method of Blix (1964),
no anti-urokinase content was demonstrated in any of the
euglobulin fractions precipitated at pH 6.0.
Unlike the baseline studies, the sex difference in





RESTING LEVELS AND EXERCISE RESPONSES IN A
1
, , M., I 1 1 1 VI" I1. , ■ 1 ~ ' " ■ ■■■■ " ,ll'"l ,i|—i-J -LLJiJiL-.
GROUP OF 50 NORMAL MIDDLE-AGED SUBJECTS
1. Resting levels of plasminogen activator
The results in Table 6 were similar to those observed
in the young subjects: the resting level of plasminogen
activator, as measured by the euglobulin lysis time,
varied from subject to subject (range 69-365 min., mean
232 min., standard deviation 191 min.) and from day to day
in some subjects.
There was no statistically significant difference
between the sexes in the middle-aged group ( 0.12=»p«c.0.2 )
nor between the total young and middle-aged populations
(0. ir»pc0.2) .
2. Exercise response studies
The fibrinolytic response was calculated as previous¬
ly and the results of all experiments are shown in Table
6. There was good individual reproducibility of response
(r = 0.787 : p<c.0.001) and a highly significant variation
h' ?2~ -
TABLE 6
SUGLOBULIH LYSIS TIMES BEFORE ill© AFTER MODERATE EXERCISE
IN MIDDLE-AGED MALE AMD FEMALE SUBJECTS
M A L S3 FEMALES
Subj.
Euglobulin
Lysis Time 55 Mean fa Subj.
Euglobulin
Lysis Time ef> Mean ^
No.
Before After

























































































































































+Cigarette smokers ( 10/day)
;*Pos t-menopausal women




Lysis Time 70 Mean Jo Subj.
Euglobulin
Lysis Time * Mean Je






































































































































































+Cigarette smokers ( 10/day)
*Post-menopausal women




Lysis Time % Mean fa Subj.
Euglobulin































































































+Cigarette smokers ( 10/day)
*Post-menopausal women
between individuals (analysis of variance showed F = 28.4,
which was significant at the 1% level). There was a
significantly higher response in the female group compared
to the males ( 0. 02is»p^0. 05) , but no significant differ¬
ence in the response between the middle-aged and young
groups as a whole ( 0. 4>p«<0. 5) (Fig. 13).
Comment
There are four important factors which mitigate
against a satisfactory analysis of the results on the
effect of age, sex and fibrinolysis: (1) the study was
not linear and therefore cross-sectional in nature, (2)
the numbers involved were relatively small and the measure¬
ments obtained had a high standard deviation, (3) only 13
of the middle-aged females were post-menopausal and even
♦
in this group the mean duration of the menopause was only
4.2 years, and (4) it was not possible to compensate for
differences in energy expenditure for the same submaximal
exercise procedure between the young and the middle-aged
groups.
Previous studies on the effect of age and fibrino¬
lysis are sparse and contradictory. Buckell and Elliot
(1959) and Swan (1963) report ed a diminished level of
fibrinolysis with increasing age, whereas Hume (1961 )
observed an increase. No change was demonstrated by
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Frequency distribution of percentage response to moderate
exercise in young and middle-aged subjects.
71-00
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Hajjar ( 1966), so that the results of this present study-
are in agreement with these authors' conclusions.
The absence of a sex difference in the euglobulin
lysis times is in contrast to the findings in the younger
group. This observation was not influenced when the
post-menopausal women were excluded from the statistical
analysis. It is possible that the presence of a higher
proportion of cigarette smokers in the middle-aged female
group (8/25) compared to the young female group (1/25) was
an important factor. When the middle-aged non-smoking
females were compared with the total middle-aged male
group (9/25) smokers, then the difference was almost
statistically significant ( 0. 05r=a.p<=: 0. 1 ) ; furthermore,
the middle-aged smoking population had a significantly
prolonged mean resting euglobulin lysis time compared to
the non-smoking population ( 0. 01i=»-p«=0. 02 ). These results
once again emphasise the fact that cigarette smoking may
prove to have a deleterious effect on the resting level
of circulating plasminogen activator, as measured by the
euglobulin lysis time.
Within the middle-aged group the findings of the
fibrinolytic response experiments were similar to those in
the young group: good individual reproducibility, signi¬
ficant variation between individuals and the isolation of
a group of poor responders. There also appeared to be a
higher response in the females compared to the men (0.02
Z^p«=^0.05) but this was less significant than the sex
- 75 -
difference observed in the young group (0.001^ p^ 0.01 } .
Although there was no significant difference in the mean
responses of the pre- and post-menopausal middle-aged
women, it was of interest to note that one of the middle-
aged poor responders was a post-menopausal woman: no poor
responders were demonstrated in the young female subjects.
Despite these remarks no firm conclusions are yet possible,
but there is at least suggestive evidence that the marked
sex difference in fibrinolytic response to exercise in the
young subjects may be diminished later in life. This
type of shift was demonstrated in the pulse rate responses
in this study (Table 7) and was also demonstrated by
Becklake et al. (1965).
Evidence is available, from other sources, which
shows that with increasing age there is a concomitant in¬
crease in energy expenditure for any fixed submaximal
exercise procedure (Durnin and Mikulicic 1956, Shock 1964,
Becklake et al. 1965, Hanson et al. 1966), and that this
is masked by isolated studies on pulse rate responses
O
(Robinson 1938, Astrand 1958, Asmussen and Mathiasen 1962,
Dill and Consolazio 1962, Hollman 1963, Strandell 1964).
Fig. 14 shows the fibrinolytic response to various grades
of exercise and demonstrates the increased fibrinolytic
response with increasing severity of exercise. In view
of the expected higher energy expenditure in the middle-
aged subjects, the finding of no statistically significant
difference in fibrinolytic response between the two age-
TABLE 7
PULSE RATE CHANGES IN MIDDLE-AGED SUBJECTS




















1 10 70 150 + 80 1 47 69 126 + 57
2 49 65 125 + 60 2 72 71 150 + 79
3 53 59 150 + 91 3 62 70 152 + 82
4 36 52 116 + 64 4 46 79 150 + 71
6 52 57 142 + 85 5 51 74 157 + 83
8 48 70 150 + 80 6 66 76 140 + 64
9 52 58 143 + 85 7 50 75 150 + 75
10 53 68 150 + 82 8 74 65 150 + 85
11 37 58 120 + 62 9 32 82 148 + 66
12 45 69 140 + 71 10 59 72 145 + 73
13 50 68 136 + 68 11 62 75 159 + 84
15 55 70 130 + 60 12 15 34 154 + 70
16 42 75 152 + 77 13 47 90 152 + 62
18 33 61 125 + 64 34- 44 70 150 + 80
19 48 67 145 + 78 15 46 93 153 + 65
20 34 67 120 + 53 16 63 75 143 + 68
21 33 70 130 + 60 17 43 71 151 + 30
22 59 64 155 + 91 18 54 79 164 + 85
23 10 80 146 + 66 19 49 - - -
24 48 58 138 + 80 20 47 84 164 + 80
25 40 65 150 + 85 24 40 72 159 + 87




Fig.K. The euglobulin lysis times of a subject before and after walking at different speeds
at a fixed elevation of 5°.
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groups may prove to be an important observation. More
detailed studies are indicated in which subjects are com¬
pared following exercises of comparable energy expendi¬
tures: such a project would prove to be a formidable
task.
Cigarette smoking appeared to have no influence on






Six middle-aged male subjects, three known to be poor
responders (10-20%) and three moderate responders (40-50%)
to the standard exercise procedure, were studied before
and after an exercise procedure designed to achieve ex¬
haustion within an 8 minute period. This involved walk¬
ing on the treadmill at an elevation of 10° for 3 minutes
at 3,4 m.p.h. followed by 3 minutes at 3.7 m.p.h., then 1
minute at 4.0 m.p.h. and if possible a further minute at
4.2 m.p.h.
All subjects spontaneously terminated the exercise
between the 50-60 second period of the final minute. The
mean post-exercise pulse rate was 198/min. The results
of the euglobulin lysis times before and after the exer¬
cise are shown in Table 8.
- 79 -








Fibrinolytic response to exhaustive
exercise in 3 known moderate responders
and 3 known *poor responders to the
standard exercise procedure.
Comment
The purpose of this small series of experiments was
to demonstrate that, even under extreme exhaustive condi- I
tions, it was still possible to differentiate between the
!good and bad responders. These observations confirm the
finding of a plasminogen activator production defect in
these poor responders and suggest that the standard exer¬






FIBRINOLYTIC RESPONSE TO MODERATE EXERCISE
AND INTRAVENOUS ADRENALINE IN THE SAME SUBJECTS
Exercise has been shown to increase plasma adrenaline,
and there appears to be some individual variation in the
level of increased adrenaline following a standardised
submaximal exercise procedure (Von Euler and Hellner 1952
; Vendsalu I960). Thus it is possible that the fibrino-
: lytic response to exercise might be mediated by the stimu
lating effects of adrenaline and that the individual
differences in fibrinolytic response are related to differ
; ences in adrenaline production. Information on this
problem would be of importance from a physiological point
of view, and might assist in a more satisfactory interpre¬
tation of the significance of the poor responders.
Adrenaline also accelerates blood coagulation in vivo
(Vosburgh and Richards 1903, Cannon and Gray 1914, Waldron
I 1951, Forwell and Ingram 1957 ). Thus, should the poor
fibrinolytic responder be explained on the basis of poor
adrenaline production, then it might be assumed that his
coagulation response would also be minimal and therefore
a coagulation fibrinolysis disequilibrium, with all its
- 81 -
proposed dangerous sequelae (Astrup 1956 ), would be un-
I ike 1y.
The absence of facilities to measure blood catechola-
,
mines necessitated the use of an indirect method of study¬
ing this problem: a comparison between the fibrinolytic
responses to exercise and a standard dose of intravenous
adrenaline.
The subjects were healthy young male and female
|volunteers aged between 18 - 30 years. Twenty-five sub- j
■
jjects were studied, 14 male (mean age: 23.4 years) and
.
II female (mean age: 21.1 years). All subjects under¬
took the standard exercise procedure described in the
previous chapters, and the intravenous adrenaline proce-
dure described in Chapter 4, on more than one occasion.
Most experiments were performed at weekly intervals, but
for 3 subjects the interval between the last exercise
procedure and the first adrenaline infusion was several
months. Subject preparation was identical to previous
exercise studies.
1. Pattern of fibrinolytic response to intravenous
adrenaline
Fig. 15 demonstrates that the maximum fibrinolytic
response, as assessed by the euglobulin lysis time,
occurred 2 minutes after the termination of the 2 minute
adrenaline infusion. On the basis of these results,
82 -
Fig.isThe euglobulin lysis time before, during and after
adrenaline infusion in 3 subjects.
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blood samples obtained for the study of the fibrinolytic
response to adrenaline were withdrawn 1 minute before and
2 minutes after the termination of the adrenaline infusion.
2. Correlation of exercise and adrenaline stimulated
fibrinolytic responses
Table 9 summarises the results of all experiments,
showing the euglobulin lysis times before and after the
exercise and adrenaline procedures. The percentage
fibrinolytic responses were calculated as described pre-
vious1y.
The results show good individual reproducibility in
response, both to exercise (correlation coefficient r =
0.9929 and p<0.001) and to intravenous adrenaline
(correlation coefficient r = 0.9949 and p<.0.001), arid a
significant degree of variation in response between indi¬
viduals (analysis of variance for exercise F = 48 and
intravenous adrenaline F = 22, both being significant at
the 1% 1evel).
Fig. 16 is a plot of the correlation between the per¬
centage fibrinolytic response to exercise and intravenous
adrenaline in all subjects. A highly significant correla¬
tion was demonstrated (correlation coefficient r = 0.855
and pCO . 001 ) .
TABLE 9
8 3 -
THE FIBRINOLYTIC RESPONSE TO EXERCISE AND




















































































































































































TABLE 9 - continued




























































































































































































































TABLE 9 - continued

























































































































% Response to i.v. Adrenaline
Fig.i6. Correlation between the percent increase in euglobulin
lysis time to moderate exercise and i.v. adrenaline.
r = 0-855, p<0.001, y = 0-92x - 3 4
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Comment
The demonstration of a good correlation between the
!
fibrinolytic response to a standard exercise and intra¬
venous adrenaline would seem to indicate, indirectly, that
the variation in fibrinolytic response to exercise between
individuals cannot be explained entirely on the basis of
individual variability of adrenaline production to exer¬
cise. These findings are regarded as further proof of
the existence of a small group of apparently healthy young
persons whose mechanisms for increasing circulating plas¬
minogen activator to stress appears to be defective. No
data are at present available which can elucidate the
mechanics of this defect. It is nossible that it might
arise due to an abnormality in the mechanisms governing
the release of the plasminogen activator from the avail¬
able stores in the vessel walls (Todd 1959, Warren 1963,





THE EFFECT OF MENTAL STRESS ON
FIBRINOLYTIC REACTIVITY TO EXERCISE
During the earlier part of this work it was assumed
that the ability to generate plasminogen activator follow¬
ing exercise was, in part, genetically determined. Sub¬
sequent studies, reported in this chapter, would indicate
that at least one environmental factor, in the form of
mental stress, can influence this phenomenon.
Five male medical student volunteers were studied
before, during and after a resit examination for the 2nd
M.B., Ch.B. Five age and sex matched control volunteers
were studied simultaneously. The control group were not
sitting examinations, but enjoying their summer vacation.
The mean percentage fibrinolytic responses to the
standard exercise procedure in the control subjects were
39, 47, 52, 50 and 36 respectively. There was good indi¬
vidual reproducibility throughout the period of study.
The results of the examination candidates are summar¬
ised in more detail in Table 10 and shown graphically in
Fig. 17. Three of the 5 subjects, immediately prior to
or during the examination period, failed to respond,
-"jl ; xo g (>■-?-7
ME FIBRINOLYTIC RESPONSE TO A I.IODERATE IXM0I3E '.JOCEUJEE BEFORE, DORINQ AND FOLLOWING AN EXA.MIHATI0N
Subject
No.






















































































































































































































































































































DAYS BEFORE AND AFTER ONSET OF EXAMINATION
Fig.iz, PERCENTAGE RESPONSE (E.L.T.) TO MODERATE EXERCISE IN 5 MALE SUBJECTS
BEFORE. DURING AND AFTER AN EXAMINATION.
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whereas the remaining 2 showed no such deterioration.
This failure of fibrinolytic response could not be explai¬
ned by a fall in plasminogen, rise in fibrinogen or the
presence of a urokinase inhibitor in the post-exercise
euglobulin solutions. The findings of the euglobulin
solutions tested on unheated human fibrin plates would
further support the view that a production defect of plas¬
minogen activator had occurred.
Comment
The results of this small study would indicate that
prolonged mental stress may produce a deleterious influence
on a normally good fibrinolytic reactivity and that this
effect may persist to a lesser degree for some weeks
beyond the end of the crisis. Of no less interest was
the observation that 2 of the 5 subjects showed no signi¬
ficant change in their fibrinolytic reactivity throughout
the period of the study. The author was unable to con¬
vince himself that these 2 subjects were less anxious than
their 3 colleagues. There was no correlation between the
presence or absence of the deleterious effect on the
fibrinolytic reactivity and the results of the degree
examination.
The mechanism of this effect of prolonged mental
stress on fibrinolytic reactivity to exercise remains
obscure. Acute anxiety stimulates fibrinolysis
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(Macfarlane and Biggs 1946, Truelove 1951, Schneider and
Zangari 1951, Ogston et al. 1962, Ogston 1964, Patsch
1965), and it is possible that prolonged mental stress
may effect a partial exhaustion of the production mechan¬
isms which are responsible for the post-exercise increase.
Such exhaustion has been proposed following prolonged
exercise (Ogston and Fullerton 1961) and severe trauma
(Bergentz and Nilsson 1961, Innes and Sevitt 1964).
The absence of a significant fall in the resting
level of plasminogen activator, as measured by the euglob-
ulin lysis time, coincident with this deleterious effect
on the fibrinolytic reactivity to exercise, might be re¬
garded as failing to substantiate the hypothesis of par¬
tial exhaustion of the activator input system. It is
possible, however, that either the liver, which controls
the removal of circulating plasminogen activator
(Fletcher et al. 1964, Janusko et al. 1966), can compen¬
sate by reducing activator clearance, or the production of
plasminogen activator which governs the resting level of
fibrinolytic activity may be largely contributed to by
sources or control mechanisms not directly related to the
exercise response phenomenon. This latter concept has
support from the work of Amery et al. (1965) in their








The standard exercise and adrenaline procedures, des¬
cribed in the previous chapters, were of relatively short
duration. It might be argued that poor responders to
this limited challenge could compensate when a prolonged
stimulus was applied.
This problem was studied in 11 volunteers, whose
fibrinolytic response to the standard exercise procedure
had been determined previously, by exercising them for 3
hours on a level treadmill at 4.00 m.p.h. following a 30
minute rest period. At hourly intervals the treadmill
was stopped for 30 seconds, during which time a sample of
blood was obtained from a cubital vein. Fluid in the
form of orange juice was provided ad lib.
The results are summarised in Tables 11 and 12 and
graphically in Fig. 18. The fibrinolytic activity, as
measured by the euglobulin lysis time and fibrin plate
method, increased during the exercise procedure and
plateaued at 2 hours in all but one subject. One subject
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Fig. 18. The euglobulin lysis time before and
during a period of prolonged exercise.
The continuous line represents the mean,
with the range, of 10 subjects. The
interrupted line represents the response
of subject M.A. (see text).
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time no further increase or subsequent decrease in the
level of fibrinolysis occurred. There was no significant
difference in euglobulin plasminogen, fibrinogen or plasma
urokinase inhibitor levels before and after the exercise
procedure in those subjects studied (Table 12).
Comment
These results confirm the finding of Ogston and
Fullerton (1961) that a steady state of fibrinolysis
following prolonged exercise is usually reached at approxi¬
mately the 2 hour mark. This observation was not, however,
applicable to one subject (M.A.) who, assuming he could
reach the level of the other subjects, had not plateaued
even at the 3 hour mark (Fig. 18). This finding could
not be explained by the low level at which he started
prior to the exercise, for comparison with another subject
(G.McK.), whose pre-exercise level was similar, shows the
marked difference between these two subjects (Fig. 19).
It is of some interest to note that subject M.A. had
also been shown to be a poor responder to both the stan¬
dard and the exhaustive exercise procedures. However,
another subject (W.G.), while known to be a poor responder
to short duration procedures, displayed a response similar
to the normal group in the prolonged exercise situation.
This would indicate that there are two types of poor res¬
ponder: those who show an abnormal response to short
- 93
Fia. 19. A comparison of the fibrinolytic
response to the prolonged exercise
procedure between two subjects
</ . :c'\. and . .) whose pre-exercise
euglobulin lysis times were similar.
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duration stress only, and those whose response is defective
to both long and short term stimulation.
The finding that, despite a wide range in the resting
euglobulin lysis times (77-780 min.) in the 10 remaining
subjects, the final time plateaued between 40 - 80 minutes
was unexpected but of considerable interest. It is sug¬
gested that this observation would indicate that a compari
son of euglobulin lysis times between normal individuals,
provided the assay techniques are satisfactory, is valid.
It is also proposed that this finding could be interpreted
as demonstrating that the difference in resting levels of
plasminogen activator between individuals may represent
normal differences in the homeostatic mechanisms control¬
ling the complex multifactorial in vivo thrombolysis.
Thus the level of circulating activator in the resting
state would not be necessarily a mirror of the level of
active thrombolysis for the individual susceptibility of
deposited fibrin to lysis could be an important modulating
factor. In situations of stress, however, when rapid
dynamic changes in fibrinolysis may be required, the
ability of the individual to augment the level of activatoi
could be the most important single factor.
Further progress in this aspect of fibrinolysis is
unlikely without new techniques which make it possible to
assess the level of overall in vivo thrombolysis. The
recent introduction of a sensitive immunological assay of
fibrin/fibrinogen degradation products (Merskey et al.
- 95 -





The significance of the fibrinolytic reactivity to
exercise and adrenaline remains, as yet, unknown. It is
postulated that it may represent, in part, the ability of
the individual to generate circulating plasminogen acti¬
vator to stress. Exercise and adrenaline have also been
shown to increase the coagulability of the blood (Vosburgh
and Richards 1903, Cannon and Gray 1914, Yuori 1950,
Waldron 1951, Forwell and Ingram 1957, Bond et al. 1961,
.
:Iatridis and Ferguson 1963, Burt et al. 1964, Von Kaulla
and Von Kaulla 1964). Thus, on the basis of a dynamic
equilibrium between coagulation and fibrinolysis, an in¬
crease in fibrinolysis would be anticipated. Iatridis
and Ferguson (1963), however, observed that 11 of their 59
subjects failed to increase their circulating plasminogen
activator following strenuous exercise despite an apparent
increase in coagulability. Burt et al. (1964), in a
study of coagulation and fibrinolysis following strenuous
exercise, concluded that the mean changes were in favour
of fibrinolysis. Examination of their results in more
detail, however, shows that two of their 44 subjects gave
a poor fibrinolytic response, whereas the coagulation
changes in these subjects were similar to those in some of
the subjects giving a marked fibrinolytic response.
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Hypercoagulability and increased fibrinolysis have
also been demonstrated during acute anxiety (Ogston et al.
1962, Patsch 1963). It is suggested that the possibility
now arises that persons with a poor fibrinolytic reactivity
may be subject to transitory episodes of coagulation-
fibrinolysis disequilibrium during their day-to-day living,
The disequilibrium might arise from either an exaggerated
increase in coagulation associated with a normal increase
in fibrinolysis or vice versa. In the light of Astrup's
hypothesis these persons may be at risk to atherosclerosis
and/or thrombosis.
Evidence supporting this view is fragmentary. Cirr¬
hotic patients have a low incidence of myocardial infarc¬
tion (Grant et al. 1959, Howell and Manion I960), and it
has been shown that they may possess exaggerated fibrino¬
lytic reactivity (Weiner 1963, Fletcher et al. 1964) as
v/ell as a general tendency to hyoocoagulation (Ollendorff
et al. 1966). Von Kaulla and Von Kaulla (1964) have
provided suggestive evidence that patients with a proven
history of myocardial infarction can show an exaggerated
hypercoagulability after exercise.
There is reason to believe that atherosclerosis is
prevalent in young males (Thomas 1957, Holman et al. 1958)
and that women, during the reproductive period of their
lives, are relatively immune (Thomas 1957, Strong and
McGill 1962). The finding of a small group of apparently
normal young men with poor fibrinolytic reactivity to
- 98 -
moderate exercise, and of women in the same age-group with
a greater fibrinolytic reactivity, may prove to be of some
interest. Sufficient data are not available to compare
the effects of age on this phenomenon.
The role of mental stress in atherogenesis and throm¬
bosis remains controversial. Three mechanisms have been
postulated: intimal trauma by repeated 'whiplash' effects
on unsupported parts of the coronary arterial trunks
(Hickman et al. 1958, Texon 1957, Enos et al. 1962), the
production of a hyperlipaemia (Mysaanikov 1958, Cardon and
Gordon 1959) and the acceleration of coagulation (Schneideif and Zangari
1951, Dreyfuss 1956, Friedman e ®t al* i 1958). Pre¬
vious studies on fibrinolysis during university examina¬
tions have failed to show consistent changes in the
absolute resting levels of plasminogen activator (Truelove
1951, Truelove 1953, Sherry et al. 1959, Sawyer et al.
I960). The results of the present investigation have
confirmed these findings but have revealed a striking ab¬
normality in the fibrinolytic response to exercise during
the examination period. In the light of the hypothesis
previously discussed, on the biological significance of
the fibrinolytic reactivity to exercise, these results may
prove to have important consequences to further studies or
the relationship of prolonged mental stress, fibrinolysis
and occlusive vascular disease.
.Although the scope of this study was necessarily
limited, sufficient information has been made available
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which indicates that the capacity of an individual to
generate circulating plasminogen activator to various
physiological stimuli may have important bearings on any
further understanding of the physiological control mechan¬
isms of the fibrinolytic enzyme system. It is not related
to absolute resting levels of fibrinolysis and may prove
to play a significant role in the proposed relationships
between fibrinolysis and occlusive vascular disease, the














G.McK, M 1 M 23 164 72
J.D, M 2 M 27 163 70
I.McK. M 3 M 23 170 73
D.J. M 4 M 23 154 71
P.S. M 5 M 24 158 73
I.F. M 6 M 24 141 71
J.B. M 7 M 22 175 71
M.P. M 8 M 29 175 71
W.G. M 9 M 30 174 71
I.W. M 10 M 23 140 70
I.N. M 11 M 22 163 73
R.W. M 12 M 24 140 69
D.M. M 13 M 23 149 73
A.P. M 14 M 25 161 71
D.F. M 15 M 19 1 36 69
I .A. M 16 M 22 142 67
H.M, M 17 M 24 168 72
G, A. M 18 M 26 175 68
G. W. M 19 M 30 140 72
A.M. M 20 M 26 168 71
A.W. M 21 M 23 140 69
P.K. M 22 M 23 168 72
J.C. M 23 M 30 171 70
S.D. M 24 M 22 160 72
M.G. M 25 M 22 150 69
A. R. F 1 F 19 110 62
M.F. F 2 F 21 136 64
J.B. F 3 F 25 133 68
E.C. F 4 F 30 150 65
J.T. F 5 F 30 126 70
F.Sp. F 6 F 20 144 67
R.W. F 7 F 20 147 69
H.S. F 8 F 19 143 62
R.L. F 9 F 19 112 66
K. A. F 10 F 19 129 63
S.E. F 11 F 21 128 66
T.G. F 12 F 20 141 66
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.
Subj ect Subject Wei ght Height
Initials Number* Sex Age (lbs) (inches)
A, B. F 13 F 20 154 69
A. H. F 14 F 20 126 64
P.B. F 15 F 23 136 67
I.B. F 16 F 22 147 62
L.W. F 17 F 19 140 67
M.L. F 18 F 19 109 62
F.S. F 19 F 19 133 62
M.K. F 20 F 19 112 62
C.W. F 21 F 23 112 63
I.S. F 22 F 23 140 67
M.H. F 23 F 22 114 63
M,Law. F 24 F 24 112 65
E.A. F 25 F 25 140 65
M.A. 1 M 46 203 69
J.D. 2 M 50 190 72
B.C. 3 M 42 187 70
R.C. 4 M 58 146 68
T.D. 5 M 50 172 66
A. E. 6 M 48 174 67
B.L. 7 M 48 136 67
T.W. 8 M 54 156 67
S.R. 9 M 55 196 71
P.B. 10 M 47 163 70
W.T. 11 M 50 166 66
T.L. 12 M 46 161 68
D.G. 13 M 50 177 68
C.G. 14 M 45 208 72
J.B. 15 M 52 196 73
J.L. 16 M 49 172 70
C.D. 17 M 55 169 64
R. A. 18 M 46 182 73
T.S. 19 M 57 187 71
G.G. 20 M 54 135 64
P.C. 21 M 53 175 67
J.P. 22 M 44 185 71
W.G. 23 M 54 161 67
J.K. 24 M 50 173 70
F.O'N. 25 M 46 161 70
W.H. 1 F 54 119 62
J.M. 2 F 55 127 61
H.W. 3 F 49 171 65
P.R. 4 F 54 116 62
C.P. 5 F 50 145 63
C. M» 6 F 53 133 62
M. D, 7 F 46 167 66
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Subj ect Subject Weight Height
Initials Number* Sex Age (lbs ) (inches)
A.A. 8 F 46 185 66
I.McL. 9 F 51 140 65
E.T. 10 F 51 128 62
E. R. 11 F 42 121 61
A.W. 12 F 45 158 65
L.C. 13 F 47 116 63
J.W. 14 F 45 143 64
E.B. 15 F 44 137 63
M.B. 16 F 47 154 68
M.H. 17 F 56 145 70
A. B. 18 F 57 140 61
Mg t .W. 19 F 51 112 59
J.S. 20 F 53 119 62
J.McM. 21 F 45 134 63
A.P. 22 F 47 158 63
H.Y. 23 F 45 154 66
J.A. 24 F 57 168 60
M.G. 25 F 50 112 63





V = —-i-, <Ex 2 - (Ejt''2 ♦ Ex.2 - 'E]C2'2jnl 2 nl n2
i.D. = V
t = xj - x2
;.d. 11 + i
V nl n2
V = Variance.
S.D. ss Standard Deviation.
Xj - = Difference between the mean values of the
groups under examination.
2 2
Ex^ , EX2 s Sum of the squared observations in
groups 1 (Xj) and 2 (x^)'
2 2
(EXj) , (5^2) = Sum of the observations of groups
1 (Xj) and 2 (*2) all squared.
n^, n2 = Total observations in groups (n^) and
2 (n2).
p (probability) was obtained by observing the rela¬
tionship between the total degrees of freedom minus one anc
the value of t in the students t - distribution tables*.
Values of p equal to or less than 0.05 were regarded as
significant.
» 1(4 —










Between Varieties £T.2/n. - C K - 1 M
Residual Varieties By Subs tract ion N - k s2
TOTAL EXj.2 - C N - 1 «■»
N = total number of observations.
G = (grand total) = Ex ^ .
2




2 - C) - (ET^/nj - C)S * yy-—
k = number of subjects.
T. ss total of each subject.
n^ » number of observations for each subject.
Significance levels were obtained by using the F -
distribution tables* where the degrees of freedom for the
numerator fj = k - 1 and the denominator ^ = N - k.
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3. Correlation Coefficient
r = Mx - x)(y - y)
y/E(x - x)^ E(y - y) 2
Where r = correlation coefficient,
x and y = each observation in groups x and y.
x and y = mean of observations in groups x and y.
The probability (p) of x and y being correlated was
obtained by comparing the value of (r) with the degrees of
freedom minus one in The Correlation Coefficient Tables*.
4. Fitting a Regression Line
The time regression line was taken as
y = a + bx
a and b were obtained as follows:-
v E<x " x)(y - y)JJJ ——ll ■ III M I IB
E(x - x)2
and a = y - bx
These results were inserted into y = a + bx and the
regression line drawn for various arbitrary values of x.
*The statistical tables used were an abridged form from
Statistical Tables for Biological, Agricultural and Medical
Research, published by Oliver and Boyd Ltd., Edinburgh.
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CONSTITUENTS OF REAGENTS
A. R ,'G NTS FOR FIBRINOGEN ESTIMATION
(1 ) Solution of -Amino-Caproic Acid (E.A.C.A.) in saline,
(1 1it re).
710 mgm. E.A.C.A. were dissolved in 1 litre of 0.9%
saline.
(2) Solution of Thrombin 100 units/ml. in saline.
(100 ml.).
The contents of 2 vials of Parke Davis thrombin were
dissolved in a small quantity of 0.9% saline. The solu¬
tion was transferred quantitatively to a 100 ml. volu¬
metric flask, ensuring that the vials were thoroughly
rinsed with 0.9% saline and made up to 100 ml. with 0.9%
saline. 1.5 ml. volumes were dispensed into 5 ml. plastic
vials and stored at -20° C.
(3) Solution of Calcium Chloride 2.5% in saline.
(500 ml■).
12.5 gm. anhydrous calcium chloride were dissolved in
500 ml. 0.9% saline.
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(4) Solution of Sodium Hydroxide 10%. (500 ml.).
50 gm. sodium hydroxide were dissolved in 500 ml.
distilled water.
(5) Solution of Trichloroacetic acid 5%. (500 ml.).
25 gm. trichloroacetic acid were dissolved in 500 ml.
distilled water.
(6) Solution of Sodium Hydroxide 0.5N. (500 ml.).
10.0 gm. sodium hydroxide were dissolved in 500 ml.
distilled water and standardised against N hydrochloric
acid solution.
B- REAGENTS FOR PLASMINOGEN ESTIMATION
(1) ^/6 Solution of Hydrochloric Acid. (500 ml.).
7.5 ml. of concentrated hydrochloric acid were added
to 500 ml. of distilled water and standardised against N
NaOH using Bromothymol blue as indicator.
(2) N/6 Solution of Sodium Hydroxide. (500 ml.).
3.33 gm. of sodium hydroxide were dissolved in 500 ml.
- 108 -
distilled water and standardised against ^/6 HC1 using
Bromothymol blue as indicator.
(3) 0.1M Phosphate Buffer pH 7.6
(i) 13.6 gm. potassium dihydrogen phosphate were dis¬
solved in 1 litre of distilled water (Solution A).
(ii) 14.2 gm. disodium hydrogen phosphate were dis¬
solved in 1 litre of distilled water (Solution B).
1 litre 0.1M phosphate buffer pH 7.6 was prepared by
mixing 870 ml. of Solution A and 130 ml. of Solution B.
(4) Streptokinase
The contents of 1 vial of Lederle Varidase St repto-
kinase-Streptodornase were dissolved in 10 ml. 0.1M phos¬
phate buffer pH 7.6.
(5) Ca sein
(i) 65 gm. of Casein were boiled in 1 litre of a
50:50 mixture of 0.9% saline and G.1M phosphate buffer
pH 7.6 for 20 minutes. During the boiling the solution
v/as stirred vigorously.
(ii) The casein solution was then dialysed against
-109-
running tap water overnight.
(iii) The casein solution was then dialysed against
0.1M phosphate buffer for 5-6 days. The buffer was
changed twice daily.
(iv) After dialysis the casein solution was centri-
fuged to remove any undissolved material. A protein
estimation was performed on the clear supernatant and
final dilution to 5 gm.% with the 50:50 mixture of 0.9%
saline and 0.1M phosphate buffer was made. The casein
was then dispensed in 6.5 ml. quantities and stored frozen
at -20° C. in plastic tubes.
c. general reagents
(1) Tris Buffer dH 7.8. (4 litres).
73 gm. tris hydroxymethyl amino methane (Koch Light
Laboratories) were dissolved in 2 litres of distilled
water and the pH adjusted to 7.8 with N HC1. The volume
was then made up to 4 litres with distilled water and the
pH checked.
(2) Barbiturate Buffer pH 7.4.
(a) Stock buffer (Veronal acetate base)
- 110 -
9.714 gm. sodium acetate trihydrate and 14.714 gm,
sodium diethyl barbiturate were dissolved in 500 ml. of
distilled water and stored at +4° C.
(b) Working buffer (Veronal acetate buffer pH 7.4)
25 ml. of the stock veronal acetate buffer were
mixed with 25 ml. 0.1 N HC1 and made up to 500 ml. with
0.9% saline. The pH was adjusted to 7.4 with either 0.1
N HC1 or 0.1 N NaOH. This working buffer was stored at
+4° C.
(3) Thrombin Solution for E.I..T. (Solution of 5 units/ml.
in Veronal Acetate Working Buffer; 2 litres).
The contents of 2 vials of Parke Davis thrombin
(5000 N.I.H. units per vial) were dissolved in 2 litres of
working veronal acetate buffer. This thrombin solution
was stored in plastic tubes at *20° G. in 4 ml. aliquots.
(4) Thrombin Solution for Fibrin Plates (50 units/ml. in
tris buffer, 200 ml.).
The contents of 2 vials of Parke Davis thrombin
(5000 N.I.H. units per vial) were dissolved in 200 ml.
tris buffer pH 7.8, and stored in 2 ml. aliquots at -20° C,
in plastic vials.
- Ill -
(5) Concentrated Human Fibrinogen for Fibrin Plates
7.5 gm. human fibrinogen (Kabi) were dissolved in
500 ml. tris buffer pH 7,8, and stirred gently at 37° C.
in a water-bath.
The solution was dispensed in 4.2 ml. and 1.1 ml.
aliquots and stored in plastic tubes at -20° C. until
required.
(6) Urokinase Control Solution for Fibrin Plates
3 units/ml. (800 ml.).
The contents of one vial of Urokinase (2400 Ploug
units) were dissolved in 800 ml. tris buffer, and dispen
sed in 1 ml. aliquots in 5 ml. plastic tubes and stored
-20° C. until required.
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CLEANING AND SILICONING OF GLASSWARE
1. CLEANING OF GLASSWARE
(a) All glassware was immersed for at least 24 hours
in a strong detergent solution of Pyroneg (Diversey (U.K.)
Ltd.).
(b) Boiled for 30 minutes in a strong solution of
Pyroneg.
(c) Rinsed free of Pyroneg in running tap water for
5 hours.
(d) Immersed in chromic acid cleaning fluid for at
least 24 hours.
(e) Rinsed free of chromic acid in running tap water
for 12 hours.
(f) Rinsed in 3 changes of distilled water.
(g) Dried in a hot air oven overnight.
2« SILICONISATION OF GLASSWARE
(a) The glassware was totally immersed in a 3% solu¬
tion of I.C.I. M550 silicone in trichlorethylene for 2
hours.
113
(b) Dried in a hot air oven overnight.
(c) Rinsed thoroughly in distilled water (6 changes).
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